Gene Symbol | Gene ID | Gene Info |
---|---|---|
Sp1
|
ENSMUSG00000001280.6 | trans-acting transcription factor 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr15_102406111_102406291 | Sp1 | 58 | 0.946722 | 0.65 | 7.1e-08 | Click! |
chr15_102406566_102406757 | Sp1 | 94 | 0.936294 | 0.62 | 4.0e-07 | Click! |
chr15_102406310_102406535 | Sp1 | 42 | 0.949856 | 0.62 | 4.6e-07 | Click! |
chr15_102405863_102406047 | Sp1 | 188 | 0.888861 | 0.60 | 1.3e-06 | Click! |
chr15_102405584_102405798 | Sp1 | 452 | 0.678928 | 0.60 | 1.6e-06 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr18_24259035_24259422 | 44.44 |
Gm7701 |
predicted gene 7701 |
1850 |
0.37 |
chr14_48475621_48476075 | 43.94 |
Tmem260 |
transmembrane protein 260 |
3526 |
0.2 |
chr15_98608664_98610204 | 39.21 |
Adcy6 |
adenylate cyclase 6 |
598 |
0.55 |
chr4_140701770_140702866 | 38.17 |
Rcc2 |
regulator of chromosome condensation 2 |
845 |
0.47 |
chr1_33600072_33600973 | 35.79 |
Gm37618 |
predicted gene, 37618 |
16310 |
0.15 |
chrX_142680720_142682167 | 35.65 |
Tmem164 |
transmembrane protein 164 |
25 |
0.98 |
chr3_52985507_52985880 | 35.48 |
Cog6 |
component of oligomeric golgi complex 6 |
8992 |
0.16 |
chr2_174329445_174331091 | 33.88 |
Gnas |
GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus |
19 |
0.97 |
chr14_20793233_20794132 | 33.12 |
Camk2g |
calcium/calmodulin-dependent protein kinase II gamma |
284 |
0.68 |
chr6_125095392_125097556 | 31.54 |
Chd4 |
chromodomain helicase DNA binding protein 4 |
95 |
0.84 |
chr17_34898151_34899707 | 30.44 |
Ehmt2 |
euchromatic histone lysine N-methyltransferase 2 |
25 |
0.87 |
chr9_65826224_65827697 | 29.55 |
Zfp609 |
zinc finger protein 609 |
604 |
0.65 |
chr5_109557850_109558797 | 29.52 |
Crlf2 |
cytokine receptor-like factor 2 |
613 |
0.67 |
chr7_25249061_25250506 | 29.06 |
Erf |
Ets2 repressor factor |
947 |
0.33 |
chr7_28179836_28180482 | 28.72 |
Dyrk1b |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1b |
107 |
0.93 |
chr17_30004516_30005139 | 27.32 |
Zfand3 |
zinc finger, AN1-type domain 3 |
94 |
0.55 |
chr2_153492229_153493481 | 27.26 |
4930404H24Rik |
RIKEN cDNA 4930404H24 gene |
65 |
0.82 |
chr2_48949106_48950119 | 26.79 |
Mbd5 |
methyl-CpG binding domain protein 5 |
89 |
0.8 |
chr5_137786077_137787112 | 26.47 |
Mepce |
methylphosphate capping enzyme |
69 |
0.92 |
chr6_97204968_97206158 | 26.37 |
Uba3 |
ubiquitin-like modifier activating enzyme 3 |
2 |
0.97 |
chr2_75703696_75705127 | 25.06 |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
78 |
0.81 |
chr15_79690079_79691459 | 24.81 |
Gtpbp1 |
GTP binding protein 1 |
76 |
0.92 |
chr7_133710663_133710880 | 24.72 |
Uros |
uroporphyrinogen III synthase |
699 |
0.49 |
chr11_69996486_69997590 | 24.63 |
Phf23 |
PHD finger protein 23 |
47 |
0.91 |
chr17_45685681_45686990 | 24.55 |
Mrpl14 |
mitochondrial ribosomal protein L14 |
13 |
0.54 |
chr6_120665862_120666733 | 24.49 |
Cecr2 |
CECR2, histone acetyl-lysine reader |
72 |
0.98 |
chr14_62760761_62761843 | 23.68 |
Ints6 |
integrator complex subunit 6 |
133 |
0.95 |
chr2_170130477_170131578 | 23.65 |
Zfp217 |
zinc finger protein 217 |
193 |
0.97 |
chr9_109094576_109096217 | 23.47 |
Plxnb1 |
plexin B1 |
7 |
0.95 |
chr7_25686729_25687529 | 23.38 |
Tgfb1 |
transforming growth factor, beta 1 |
127 |
0.91 |
chr5_22344110_22345571 | 23.25 |
Reln |
reelin |
138 |
0.95 |
chr11_102316544_102317735 | 23.22 |
Ubtf |
upstream binding transcription factor, RNA polymerase I |
148 |
0.92 |
chr7_127026546_127028177 | 23.18 |
Maz |
MYC-associated zinc finger protein (purine-binding transcription factor) |
324 |
0.58 |
chr3_51340298_51341882 | 22.94 |
Elf2 |
E74-like factor 2 |
427 |
0.74 |
chr11_74831594_74833056 | 22.53 |
Mnt |
max binding protein |
1405 |
0.31 |
chr10_69910043_69910940 | 22.52 |
Ank3 |
ankyrin 3, epithelial |
4374 |
0.35 |
chr10_80150235_80151164 | 22.39 |
Midn |
midnolin |
242 |
0.82 |
chr11_98766610_98767640 | 22.23 |
Nr1d1 |
nuclear receptor subfamily 1, group D, member 1 |
3301 |
0.13 |
chr15_102470670_102471447 | 22.22 |
Pcbp2 |
poly(rC) binding protein 2 |
10 |
0.95 |
chr2_51946774_51947120 | 22.21 |
Nmi |
N-myc (and STAT) interactor |
5630 |
0.18 |
chr4_156197393_156197799 | 22.08 |
Agrn |
agrin |
108 |
0.92 |
chr19_41482494_41483686 | 21.96 |
Lcor |
ligand dependent nuclear receptor corepressor |
61 |
0.98 |
chr7_133710460_133710636 | 21.26 |
Uros |
uroporphyrinogen III synthase |
476 |
0.63 |
chr11_74837693_74838808 | 21.22 |
Mnt |
max binding protein |
782 |
0.52 |
chr10_127508848_127510720 | 21.16 |
Stac3 |
SH3 and cysteine rich domain 3 |
2559 |
0.15 |
chr5_140829777_140830873 | 20.76 |
Gna12 |
guanine nucleotide binding protein, alpha 12 |
106 |
0.97 |
chr18_21299601_21300892 | 20.63 |
Garem1 |
GRB2 associated regulator of MAPK1 subtype 1 |
108 |
0.96 |
chr7_127768560_127769629 | 20.31 |
Orai3 |
ORAI calcium release-activated calcium modulator 3 |
721 |
0.4 |
chr8_107030704_107031406 | 20.24 |
Gm16208 |
predicted gene 16208 |
133 |
0.53 |
chrX_48284788_48285532 | 20.04 |
Gm22528 |
predicted gene, 22528 |
14419 |
0.13 |
chr6_72097140_72098281 | 19.95 |
St3gal5 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 5 |
47 |
0.96 |
chr8_120486990_120488549 | 19.87 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
678 |
0.64 |
chr4_129188973_129189769 | 19.81 |
S100pbp |
S100P binding protein |
127 |
0.78 |
chr10_80576603_80578409 | 19.70 |
Klf16 |
Kruppel-like factor 16 |
185 |
0.86 |
chr11_70021148_70021981 | 19.68 |
Dlg4 |
discs large MAGUK scaffold protein 4 |
2356 |
0.11 |
chrX_42067696_42069057 | 19.67 |
Xiap |
X-linked inhibitor of apoptosis |
22 |
0.98 |
chr7_118243052_118244285 | 19.51 |
Smg1 |
SMG1 homolog, phosphatidylinositol 3-kinase-related kinase (C. elegans) |
2 |
0.72 |
chr11_77607040_77608322 | 19.30 |
Taok1 |
TAO kinase 1 |
134 |
0.94 |
chr13_45389281_45390472 | 19.24 |
Mylip |
myosin regulatory light chain interacting protein |
134 |
0.97 |
chrX_51204673_51205680 | 19.13 |
Mbnl3 |
muscleblind like splicing factor 3 |
656 |
0.65 |
chr5_149229091_149229712 | 18.80 |
2310047D07Rik |
RIKEN cDNA 2310047D07 gene |
1931 |
0.18 |
chr3_100488535_100489982 | 18.76 |
Tent5c |
terminal nucleotidyltransferase 5C |
60 |
0.85 |
chrX_169997850_169998483 | 18.69 |
Gm15247 |
predicted gene 15247 |
11227 |
0.14 |
chr2_153528510_153529333 | 18.67 |
Nol4l |
nucleolar protein 4-like |
1050 |
0.54 |
chr11_98741567_98742727 | 18.60 |
Thra |
thyroid hormone receptor alpha |
11 |
0.95 |
chr1_134559997_134561478 | 18.60 |
Kdm5b |
lysine (K)-specific demethylase 5B |
530 |
0.69 |
chr9_61370339_61371660 | 18.58 |
Gm10655 |
predicted gene 10655 |
628 |
0.63 |
chr1_166002288_166003185 | 18.56 |
Pou2f1 |
POU domain, class 2, transcription factor 1 |
58 |
0.72 |
chr15_100599610_100600576 | 18.44 |
Pou6f1 |
POU domain, class 6, transcription factor 1 |
109 |
0.48 |
chr9_106821518_106822739 | 18.42 |
Dcaf1 |
DDB1 and CUL4 associated factor 1 |
254 |
0.89 |
chr2_44926591_44927289 | 18.38 |
Gtdc1 |
glycosyltransferase-like domain containing 1 |
209 |
0.96 |
chr13_119258613_119258805 | 18.22 |
Gm44488 |
predicted gene, 44488 |
10895 |
0.22 |
chr17_29490421_29490815 | 18.06 |
Pim1 |
proviral integration site 1 |
135 |
0.84 |
chr12_118301013_118301849 | 18.02 |
Sp4 |
trans-acting transcription factor 4 |
9 |
0.99 |
chr11_88068171_88069196 | 17.90 |
Vezf1 |
vascular endothelial zinc finger 1 |
404 |
0.76 |
chr15_58140746_58142050 | 17.83 |
Wdyhv1 |
WDYHV motif containing 1 |
6 |
0.96 |
chr10_61534398_61535221 | 17.83 |
Gm17829 |
predicted gene, 17829 |
24224 |
0.1 |
chr14_40966316_40967615 | 17.83 |
Tspan14 |
tetraspanin 14 |
158 |
0.96 |
chr15_100747217_100747460 | 17.81 |
Slc4a8 |
solute carrier family 4 (anion exchanger), member 8 |
14409 |
0.11 |
chr7_133710940_133711141 | 17.47 |
Uros |
uroporphyrinogen III synthase |
968 |
0.37 |
chr14_57912393_57912544 | 17.26 |
Micu2 |
mitochondrial calcium uptake 2 |
7464 |
0.17 |
chr7_48880950_48881793 | 17.13 |
Gm2788 |
predicted gene 2788 |
71 |
0.71 |
chr5_125441031_125441705 | 16.91 |
Bri3bp |
Bri3 binding protein |
200 |
0.9 |
chr11_85139345_85140659 | 16.89 |
Usp32 |
ubiquitin specific peptidase 32 |
34 |
0.97 |
chr4_107253005_107253839 | 16.85 |
Lrrc42 |
leucine rich repeat containing 42 |
110 |
0.58 |
chr9_59750348_59751247 | 16.83 |
Senp8 |
SUMO/sentrin specific peptidase 8 |
87 |
0.51 |
chr12_101028530_101029714 | 16.77 |
Ccdc88c |
coiled-coil domain containing 88C |
66 |
0.95 |
chr12_86883989_86885134 | 16.74 |
Irf2bpl |
interferon regulatory factor 2 binding protein-like |
237 |
0.93 |
chr2_156840246_156841082 | 16.67 |
Tgif2 |
TGFB-induced factor homeobox 2 |
358 |
0.63 |
chr10_77606403_77607161 | 16.64 |
Sumo3 |
small ubiquitin-like modifier 3 |
211 |
0.75 |
chrX_36988645_36990253 | 16.56 |
Septin6 |
septin 6 |
42 |
0.97 |
chrX_13070554_13071574 | 16.53 |
Usp9x |
ubiquitin specific peptidase 9, X chromosome |
434 |
0.84 |
chr5_139380266_139381195 | 16.47 |
Gpr146 |
G protein-coupled receptor 146 |
149 |
0.92 |
chr11_48816528_48817196 | 16.45 |
Trim41 |
tripartite motif-containing 41 |
91 |
0.93 |
chr14_14351950_14353283 | 16.45 |
Il3ra |
interleukin 3 receptor, alpha chain |
2995 |
0.15 |
chr12_76709620_76710348 | 16.40 |
Sptb |
spectrin beta, erythrocytic |
39 |
0.98 |
chr17_47923769_47925323 | 16.22 |
Foxp4 |
forkhead box P4 |
70 |
0.96 |
chrY_90771840_90772811 | 16.02 |
Gm47283 |
predicted gene, 47283 |
12413 |
0.17 |
chr4_152086414_152087408 | 16.02 |
Plekhg5 |
pleckstrin homology domain containing, family G (with RhoGef domain) member 5 |
53 |
0.96 |
chr2_165326390_165327162 | 15.99 |
Elmo2 |
engulfment and cell motility 2 |
297 |
0.87 |
chr11_95990909_95991822 | 15.92 |
Igf2bp1 |
insulin-like growth factor 2 mRNA binding protein 1 |
8754 |
0.09 |
chr6_49367200_49368123 | 15.77 |
Fam221a |
family with sequence similarity 221, member A |
78 |
0.97 |
chr5_137349031_137350198 | 15.76 |
Ephb4 |
Eph receptor B4 |
495 |
0.62 |
chr12_105009915_105010683 | 15.75 |
Syne3 |
spectrin repeat containing, nuclear envelope family member 3 |
490 |
0.67 |
chr17_88065293_88066116 | 15.72 |
Fbxo11 |
F-box protein 11 |
413 |
0.86 |
chr11_102393202_102394154 | 15.63 |
Rundc3a |
RUN domain containing 3A |
275 |
0.82 |
chr3_88532663_88533971 | 15.62 |
Mex3a |
mex3 RNA binding family member A |
922 |
0.31 |
chr11_117968531_117970182 | 15.58 |
Socs3 |
suppressor of cytokine signaling 3 |
95 |
0.96 |
chr14_32022577_32022765 | 15.58 |
Galnt15 |
polypeptide N-acetylgalactosaminyltransferase 15 |
6318 |
0.15 |
chr3_87910469_87910885 | 15.53 |
Hdgf |
heparin binding growth factor |
643 |
0.53 |
chr19_29805752_29806710 | 15.47 |
9930021J03Rik |
RIKEN cDNA 9930021J03 gene |
242 |
0.68 |
chr11_69837611_69838644 | 15.30 |
Nlgn2 |
neuroligin 2 |
343 |
0.43 |
chr9_44881205_44881917 | 15.28 |
Gm39326 |
predicted gene, 39326 |
167 |
0.6 |
chr5_122501856_122502977 | 15.27 |
Atp2a2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
191 |
0.88 |
chr3_85887352_85888077 | 15.27 |
4933425M03Rik |
RIKEN cDNA 4933425M03 gene |
23 |
0.56 |
chr11_87986817_87988025 | 15.27 |
Dynll2 |
dynein light chain LC8-type 2 |
65 |
0.96 |
chr9_110653586_110654769 | 15.27 |
Nbeal2 |
neurobeachin-like 2 |
16 |
0.94 |
chr8_70698268_70700333 | 15.23 |
Jund |
jun D proto-oncogene |
351 |
0.45 |
chr11_97744788_97745005 | 15.22 |
Mir8102 |
microRNA 8102 |
1 |
0.69 |
chr11_97884065_97884612 | 15.20 |
Fbxo47 |
F-box protein 47 |
184 |
0.58 |
chr15_81585272_81586453 | 15.16 |
Gm23880 |
predicted gene, 23880 |
271 |
0.52 |
chr5_134551282_134552920 | 15.11 |
Gm42884 |
predicted gene 42884 |
44 |
0.81 |
chr6_90988622_90989360 | 15.08 |
Iqsec1 |
IQ motif and Sec7 domain 1 |
306 |
0.9 |
chr6_124919273_124920636 | 15.08 |
Ptms |
parathymosin |
149 |
0.88 |
chr14_25606696_25608421 | 15.06 |
Zmiz1 |
zinc finger, MIZ-type containing 1 |
201 |
0.95 |
chr5_107986404_107987625 | 15.03 |
Dipk1a |
divergent protein kinase domain 1A |
19 |
0.97 |
chr11_116581477_116581809 | 14.99 |
Ube2o |
ubiquitin-conjugating enzyme E2O |
196 |
0.88 |
chr8_89042876_89043891 | 14.95 |
Sall1 |
spalt like transcription factor 1 |
779 |
0.7 |
chr18_35829993_35830906 | 14.90 |
Cxxc5 |
CXXC finger 5 |
135 |
0.85 |
chr11_78163296_78164397 | 14.80 |
Traf4 |
TNF receptor associated factor 4 |
1670 |
0.14 |
chr13_58006958_58007325 | 14.59 |
Mir874 |
microRNA 874 |
16059 |
0.21 |
chr10_122096764_122097910 | 14.53 |
Rxylt1 |
ribitol xylosyltransferase 1 |
34 |
0.97 |
chr11_60176319_60177391 | 14.53 |
Rai1 |
retinoic acid induced 1 |
976 |
0.44 |
chr4_88032518_88033581 | 14.45 |
Mllt3 |
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 3 |
232 |
0.71 |
chr17_33915666_33916637 | 14.43 |
Zbtb22 |
zinc finger and BTB domain containing 22 |
20 |
0.48 |
chr5_123137669_123138894 | 14.38 |
AI480526 |
expressed sequence AI480526 |
172 |
0.79 |
chr11_74925378_74926625 | 14.36 |
Srr |
serine racemase |
53 |
0.66 |
chr11_11684707_11686418 | 14.34 |
Gm11999 |
predicted gene 11999 |
162 |
0.73 |
chr10_127512528_127514054 | 14.32 |
Ndufa4l2 |
Ndufa4, mitochondrial complex associated like 2 |
1676 |
0.21 |
chr19_4282702_4283651 | 14.31 |
Ankrd13d |
ankyrin repeat domain 13 family, member D |
39 |
0.93 |
chr4_116720426_116721428 | 14.31 |
Tesk2 |
testis-specific kinase 2 |
21 |
0.96 |
chr17_35164786_35165560 | 14.23 |
Gm17705 |
predicted gene, 17705 |
54 |
0.72 |
chr1_86525613_86527056 | 14.15 |
Ptma |
prothymosin alpha |
392 |
0.81 |
chr8_70609185_70610414 | 14.14 |
Gm45546 |
predicted gene 45546 |
626 |
0.42 |
chr19_46499799_46500492 | 14.14 |
Trim8 |
tripartite motif-containing 8 |
1557 |
0.33 |
chr4_129513695_129514851 | 14.10 |
Marcksl1 |
MARCKS-like 1 |
692 |
0.46 |
chr2_5951282_5952030 | 14.05 |
Upf2 |
UPF2 regulator of nonsense transcripts homolog (yeast) |
187 |
0.94 |
chr7_83891433_83892352 | 14.04 |
Mesd |
mesoderm development LRP chaperone |
108 |
0.78 |
chr2_34372457_34372975 | 13.99 |
Pbx3 |
pre B cell leukemia homeobox 3 |
426 |
0.84 |
chr7_16046417_16047443 | 13.97 |
Bicra |
BRD4 interacting chromatin remodeling complex associated protein |
991 |
0.44 |
chr3_144720129_144720738 | 13.96 |
Sh3glb1 |
SH3-domain GRB2-like B1 (endophilin) |
98 |
0.95 |
chr2_30807359_30808064 | 13.95 |
Ntmt1 |
N-terminal Xaa-Pro-Lys N-methyltransferase 1 |
115 |
0.94 |
chr8_84979246_84980613 | 13.92 |
Junb |
jun B proto-oncogene |
1211 |
0.19 |
chr12_8770800_8772245 | 13.86 |
Sdc1 |
syndecan 1 |
109 |
0.78 |
chr2_25982690_25983958 | 13.83 |
Camsap1 |
calmodulin regulated spectrin-associated protein 1 |
42 |
0.97 |
chr15_36792317_36793249 | 13.81 |
Ywhaz |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide |
369 |
0.84 |
chr10_80590277_80590932 | 13.76 |
Abhd17a |
abhydrolase domain containing 17A |
263 |
0.71 |
chr11_23255157_23256431 | 13.75 |
Xpo1 |
exportin 1 |
247 |
0.94 |
chr9_101251390_101252245 | 13.70 |
Ppp2r3a |
protein phosphatase 2, regulatory subunit B'', alpha |
22 |
0.97 |
chr14_77483153_77483315 | 13.70 |
Gm6994 |
predicted gene 6994 |
18206 |
0.17 |
chr5_149051995_149052486 | 13.65 |
Hmgb1 |
high mobility group box 1 |
137 |
0.93 |
chr10_127667525_127668413 | 13.58 |
Nab2 |
Ngfi-A binding protein 2 |
599 |
0.4 |
chr10_42275380_42276258 | 13.56 |
Foxo3 |
forkhead box O3 |
877 |
0.68 |
chr11_116624141_116624473 | 13.55 |
Rhbdf2 |
rhomboid 5 homolog 2 |
60 |
0.95 |
chr10_128525093_128526268 | 13.52 |
Esyt1 |
extended synaptotagmin-like protein 1 |
188 |
0.63 |
chr10_127380689_127381478 | 13.47 |
R3hdm2 |
R3H domain containing 2 |
284 |
0.81 |
chr11_60114297_60115906 | 13.45 |
4930412M03Rik |
RIKEN cDNA 4930412M03 gene |
129 |
0.95 |
chr2_154790876_154791702 | 13.45 |
Raly |
hnRNP-associated with lethal yellow |
63 |
0.56 |
chr11_102407017_102407912 | 13.43 |
Slc25a39 |
solute carrier family 25, member 39 |
1 |
0.95 |
chr10_42950072_42950669 | 13.41 |
Scml4 |
Scm polycomb group protein like 4 |
10489 |
0.19 |
chr9_106367425_106368835 | 13.38 |
Dusp7 |
dual specificity phosphatase 7 |
502 |
0.7 |
chr5_134467312_134467605 | 13.33 |
Gm16020 |
predicted gene 16020 |
4218 |
0.12 |
chr4_16163506_16164146 | 13.28 |
Ripk2 |
receptor (TNFRSF)-interacting serine-threonine kinase 2 |
179 |
0.63 |
chr12_72085046_72085908 | 13.23 |
L3hypdh |
L-3-hydroxyproline dehydratase (trans-) |
38 |
0.58 |
chr16_30063252_30064537 | 13.19 |
Hes1 |
hes family bHLH transcription factor 1 |
490 |
0.76 |
chr9_35116070_35117303 | 13.19 |
4930581F22Rik |
RIKEN cDNA 4930581F22 gene |
42 |
0.69 |
chr9_62980541_62981320 | 13.17 |
Pias1 |
protein inhibitor of activated STAT 1 |
47 |
0.98 |
chr11_51999751_52000565 | 13.16 |
Ube2b |
ubiquitin-conjugating enzyme E2B |
321 |
0.69 |
chr7_25281840_25282218 | 13.14 |
Cic |
capicua transcriptional repressor |
150 |
0.9 |
chr2_18056522_18056740 | 13.12 |
1810059C17Rik |
RIKEN cDNA 1810059C17 gene |
18 |
0.93 |
chr5_137530580_137532081 | 13.12 |
Gnb2 |
guanine nucleotide binding protein (G protein), beta 2 |
33 |
0.9 |
chr15_99295125_99295746 | 13.11 |
Prpf40b |
pre-mRNA processing factor 40B |
164 |
0.76 |
chr9_108094451_108094983 | 13.08 |
Apeh |
acylpeptide hydrolase |
111 |
0.9 |
chr16_93711386_93712056 | 13.08 |
Dop1b |
DOP1 leucine zipper like protein B |
183 |
0.93 |
chr12_51691136_51692207 | 13.08 |
Strn3 |
striatin, calmodulin binding protein 3 |
216 |
0.81 |
chr4_133967146_133967733 | 13.03 |
Hmgn2 |
high mobility group nucleosomal binding domain 2 |
2 |
0.97 |
chr10_127188430_127189698 | 13.02 |
Arhgef25 |
Rho guanine nucleotide exchange factor (GEF) 25 |
292 |
0.77 |
chr3_35753734_35754344 | 13.00 |
Atp11b |
ATPase, class VI, type 11B |
67 |
0.97 |
chr7_44985781_44987176 | 12.98 |
Prmt1 |
protein arginine N-methyltransferase 1 |
14 |
0.83 |
chr6_113377357_113377672 | 12.96 |
Tada3 |
transcriptional adaptor 3 |
3 |
0.89 |
chr2_104122426_104123415 | 12.93 |
A930018P22Rik |
RIKEN cDNA A930018P22 gene |
151 |
0.94 |
chr10_69908447_69908713 | 12.93 |
Ank3 |
ankyrin 3, epithelial |
6285 |
0.32 |
chr4_155563302_155563634 | 12.92 |
Nadk |
NAD kinase |
232 |
0.87 |
chr7_65644408_65645427 | 12.91 |
Tarsl2 |
threonyl-tRNA synthetase-like 2 |
19 |
0.98 |
chr12_108179279_108180127 | 12.90 |
Ccnk |
cyclin K |
35 |
0.86 |
chr6_83456116_83457458 | 12.89 |
Tet3 |
tet methylcytosine dioxygenase 3 |
395 |
0.77 |
chr7_128610983_128611399 | 12.88 |
Inpp5f |
inositol polyphosphate-5-phosphatase F |
137 |
0.94 |
chr15_76697423_76698657 | 12.85 |
Gpt |
glutamic pyruvic transaminase, soluble |
22 |
0.93 |
chr10_80538778_80539361 | 12.77 |
Atp8b3 |
ATPase, class I, type 8B, member 3 |
21 |
0.95 |
chr11_101467552_101468698 | 12.73 |
Rnd2 |
Rho family GTPase 2 |
50 |
0.92 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
11.6 | 34.7 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
11.5 | 34.6 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
10.8 | 32.3 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
10.7 | 32.0 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
10.6 | 42.4 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
10.4 | 31.1 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
10.1 | 20.3 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
10.0 | 30.0 | GO:0040031 | snRNA modification(GO:0040031) |
9.7 | 29.0 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
9.4 | 28.3 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
9.2 | 27.7 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
9.2 | 27.7 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
9.0 | 45.1 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
8.9 | 26.8 | GO:0071314 | cellular response to cocaine(GO:0071314) |
8.6 | 17.3 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
8.6 | 25.7 | GO:0021553 | olfactory nerve development(GO:0021553) |
8.5 | 25.4 | GO:0008050 | female courtship behavior(GO:0008050) |
8.3 | 33.2 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
8.3 | 33.0 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
8.1 | 24.4 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
8.1 | 24.2 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
8.0 | 16.0 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
8.0 | 16.0 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
8.0 | 23.9 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
7.8 | 31.2 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
7.8 | 23.3 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
7.7 | 23.1 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
7.6 | 22.7 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
7.3 | 29.3 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
7.2 | 21.6 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
7.1 | 21.4 | GO:0007525 | somatic muscle development(GO:0007525) |
7.1 | 7.1 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
7.0 | 28.1 | GO:0023021 | termination of signal transduction(GO:0023021) |
6.9 | 27.6 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
6.8 | 34.0 | GO:0072553 | terminal button organization(GO:0072553) |
6.8 | 40.5 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
6.7 | 33.5 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
6.6 | 66.4 | GO:0034063 | stress granule assembly(GO:0034063) |
6.6 | 33.2 | GO:0060789 | hair follicle placode formation(GO:0060789) |
6.6 | 26.5 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
6.6 | 19.7 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
6.5 | 13.1 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
6.5 | 32.3 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
6.4 | 38.6 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
6.4 | 25.7 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
6.4 | 6.4 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
6.4 | 19.1 | GO:0002432 | granuloma formation(GO:0002432) |
6.3 | 37.8 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
6.3 | 25.1 | GO:0090168 | Golgi reassembly(GO:0090168) |
6.3 | 68.9 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
6.2 | 12.4 | GO:0090202 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
6.2 | 12.3 | GO:1904259 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
6.1 | 12.2 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
6.1 | 30.5 | GO:1903276 | regulation of sodium ion export(GO:1903273) regulation of sodium ion export from cell(GO:1903276) |
6.0 | 23.8 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
5.9 | 35.5 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
5.9 | 23.5 | GO:0048625 | myoblast fate commitment(GO:0048625) |
5.9 | 35.3 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
5.8 | 29.1 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
5.8 | 28.8 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
5.7 | 22.9 | GO:0007296 | vitellogenesis(GO:0007296) |
5.7 | 17.2 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
5.7 | 28.6 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
5.6 | 16.9 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
5.6 | 22.4 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
5.6 | 16.8 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
5.6 | 16.7 | GO:0046208 | spermine catabolic process(GO:0046208) |
5.4 | 136.0 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
5.4 | 16.3 | GO:1903677 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
5.4 | 26.9 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
5.4 | 21.4 | GO:0071499 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
5.4 | 16.1 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
5.3 | 10.7 | GO:0045472 | response to ether(GO:0045472) |
5.3 | 15.9 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
5.3 | 21.1 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
5.3 | 26.3 | GO:1905214 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
5.2 | 15.7 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
5.2 | 15.7 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
5.2 | 10.3 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
5.2 | 5.2 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
5.2 | 15.5 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
5.1 | 15.4 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
5.1 | 15.4 | GO:0006543 | glutamine catabolic process(GO:0006543) |
5.1 | 25.5 | GO:1903242 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
5.1 | 15.2 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
5.1 | 20.3 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
5.1 | 15.2 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
5.0 | 19.9 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
5.0 | 19.8 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
4.9 | 14.8 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
4.9 | 14.8 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
4.9 | 14.7 | GO:0044838 | cell quiescence(GO:0044838) |
4.9 | 24.5 | GO:0050812 | regulation of acyl-CoA biosynthetic process(GO:0050812) |
4.9 | 14.7 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
4.8 | 9.7 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
4.8 | 19.3 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
4.8 | 9.6 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
4.8 | 19.2 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
4.8 | 14.4 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
4.8 | 28.7 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
4.8 | 4.8 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
4.7 | 19.0 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
4.7 | 14.1 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
4.7 | 28.2 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
4.6 | 27.9 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
4.6 | 18.5 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
4.6 | 9.3 | GO:0032907 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
4.6 | 18.5 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
4.6 | 13.7 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
4.6 | 13.7 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
4.5 | 22.6 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
4.5 | 67.7 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
4.5 | 22.6 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
4.5 | 4.5 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
4.5 | 31.3 | GO:0001842 | neural fold formation(GO:0001842) |
4.5 | 4.5 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
4.4 | 26.7 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
4.4 | 26.6 | GO:0016266 | O-glycan processing(GO:0016266) |
4.4 | 17.7 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
4.4 | 13.3 | GO:0042117 | monocyte activation(GO:0042117) |
4.4 | 13.3 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
4.4 | 39.8 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
4.4 | 8.8 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
4.4 | 17.6 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
4.4 | 4.4 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
4.4 | 30.5 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
4.3 | 30.4 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
4.3 | 21.6 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
4.3 | 17.3 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
4.3 | 4.3 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
4.3 | 30.2 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
4.3 | 17.2 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
4.3 | 12.8 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
4.2 | 12.7 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
4.2 | 55.0 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
4.2 | 4.2 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
4.2 | 16.8 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
4.2 | 16.7 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
4.2 | 16.7 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
4.2 | 16.7 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
4.2 | 12.5 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
4.2 | 20.8 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
4.2 | 12.5 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
4.2 | 20.8 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
4.2 | 29.1 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
4.1 | 8.3 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
4.1 | 41.4 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
4.1 | 4.1 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
4.1 | 20.5 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
4.1 | 4.1 | GO:0036258 | multivesicular body assembly(GO:0036258) |
4.1 | 8.2 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
4.1 | 12.2 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
4.1 | 16.3 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
4.1 | 16.3 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
4.1 | 20.3 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
4.0 | 20.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
4.0 | 12.1 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
4.0 | 12.1 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
4.0 | 48.4 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
4.0 | 12.0 | GO:0042938 | dipeptide transport(GO:0042938) |
4.0 | 8.0 | GO:0061687 | detoxification of copper ion(GO:0010273) detoxification of inorganic compound(GO:0061687) stress response to copper ion(GO:1990169) |
4.0 | 16.0 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
4.0 | 12.0 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
4.0 | 11.9 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
4.0 | 15.8 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
3.9 | 19.7 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
3.9 | 15.7 | GO:0051541 | elastin metabolic process(GO:0051541) |
3.9 | 11.8 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
3.9 | 11.8 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
3.9 | 31.4 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
3.9 | 23.4 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
3.9 | 3.9 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
3.9 | 11.7 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
3.9 | 3.9 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
3.9 | 7.8 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
3.9 | 34.9 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
3.9 | 3.9 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
3.9 | 15.5 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
3.9 | 11.6 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
3.8 | 23.1 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
3.8 | 15.4 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
3.8 | 15.3 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
3.8 | 3.8 | GO:0060374 | mast cell differentiation(GO:0060374) |
3.8 | 11.5 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
3.8 | 19.0 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
3.8 | 7.6 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
3.8 | 7.5 | GO:1903416 | response to glycoside(GO:1903416) |
3.8 | 7.5 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
3.8 | 7.5 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
3.7 | 7.5 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
3.7 | 7.5 | GO:0061620 | glycolytic process through glucose-6-phosphate(GO:0061620) |
3.7 | 29.7 | GO:0032986 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
3.7 | 3.7 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
3.7 | 3.7 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
3.6 | 10.9 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
3.6 | 14.5 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
3.6 | 7.3 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
3.6 | 25.4 | GO:0031507 | heterochromatin assembly(GO:0031507) |
3.6 | 21.8 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
3.6 | 14.5 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
3.6 | 18.1 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
3.6 | 3.6 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
3.6 | 7.1 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
3.6 | 10.7 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) |
3.5 | 24.7 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
3.5 | 21.2 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
3.5 | 45.5 | GO:0045116 | protein neddylation(GO:0045116) |
3.5 | 17.5 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
3.5 | 3.5 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
3.5 | 10.5 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
3.5 | 7.0 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
3.5 | 13.9 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
3.5 | 10.4 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
3.5 | 34.7 | GO:0051352 | negative regulation of ligase activity(GO:0051352) |
3.4 | 13.7 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
3.4 | 37.7 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
3.4 | 6.8 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
3.4 | 13.6 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
3.4 | 37.5 | GO:0007035 | vacuolar acidification(GO:0007035) |
3.4 | 27.2 | GO:0002115 | store-operated calcium entry(GO:0002115) |
3.4 | 23.7 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
3.4 | 16.9 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
3.4 | 16.9 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
3.4 | 6.7 | GO:0090239 | regulation of histone H4 acetylation(GO:0090239) |
3.4 | 10.1 | GO:0000087 | mitotic M phase(GO:0000087) |
3.4 | 10.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
3.4 | 3.4 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
3.3 | 10.0 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
3.3 | 6.7 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
3.3 | 10.0 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
3.3 | 10.0 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
3.3 | 59.9 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
3.3 | 36.5 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
3.3 | 19.8 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
3.3 | 13.2 | GO:0048102 | autophagic cell death(GO:0048102) |
3.3 | 9.9 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
3.3 | 3.3 | GO:0018992 | germ-line sex determination(GO:0018992) |
3.3 | 26.3 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
3.3 | 19.7 | GO:0051013 | microtubule severing(GO:0051013) |
3.3 | 13.1 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
3.3 | 9.8 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
3.3 | 3.3 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) regulation of hemoglobin biosynthetic process(GO:0046984) |
3.3 | 9.8 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
3.2 | 6.5 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
3.2 | 9.7 | GO:0009826 | unidimensional cell growth(GO:0009826) |
3.2 | 9.7 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
3.2 | 9.7 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
3.2 | 67.9 | GO:0016578 | histone deubiquitination(GO:0016578) |
3.2 | 22.6 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
3.2 | 3.2 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
3.2 | 9.7 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
3.2 | 9.6 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
3.2 | 22.5 | GO:0006563 | L-serine metabolic process(GO:0006563) |
3.2 | 12.8 | GO:0070828 | heterochromatin organization(GO:0070828) |
3.2 | 25.6 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
3.2 | 12.8 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
3.2 | 19.1 | GO:0016574 | histone ubiquitination(GO:0016574) |
3.2 | 15.9 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
3.2 | 9.5 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
3.2 | 6.3 | GO:0032803 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
3.2 | 9.5 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
3.1 | 22.0 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
3.1 | 22.0 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
3.1 | 15.7 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
3.1 | 6.3 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
3.1 | 25.1 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
3.1 | 9.4 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
3.1 | 9.4 | GO:0061157 | mRNA destabilization(GO:0061157) |
3.1 | 9.4 | GO:0006449 | regulation of translational termination(GO:0006449) |
3.1 | 6.3 | GO:0010985 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) negative regulation of lipoprotein particle clearance(GO:0010985) |
3.1 | 9.4 | GO:0019086 | late viral transcription(GO:0019086) |
3.1 | 3.1 | GO:0006551 | leucine metabolic process(GO:0006551) |
3.1 | 3.1 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
3.1 | 3.1 | GO:0046655 | folic acid metabolic process(GO:0046655) |
3.1 | 12.4 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
3.1 | 6.2 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
3.1 | 6.2 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
3.1 | 3.1 | GO:0003166 | bundle of His development(GO:0003166) |
3.1 | 9.3 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
3.1 | 9.2 | GO:0072718 | response to cisplatin(GO:0072718) |
3.1 | 9.2 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
3.1 | 6.1 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
3.1 | 12.2 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
3.0 | 12.2 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
3.0 | 9.1 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
3.0 | 12.1 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
3.0 | 6.1 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
3.0 | 9.1 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
3.0 | 21.1 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
3.0 | 15.1 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
3.0 | 24.1 | GO:0045792 | negative regulation of cell size(GO:0045792) |
3.0 | 6.0 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
3.0 | 12.0 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
3.0 | 6.0 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
3.0 | 9.0 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
3.0 | 15.0 | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
3.0 | 27.0 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
3.0 | 6.0 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
3.0 | 3.0 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
3.0 | 8.9 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
3.0 | 3.0 | GO:0010255 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
3.0 | 5.9 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
3.0 | 8.9 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
3.0 | 8.9 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
3.0 | 5.9 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
3.0 | 8.9 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
3.0 | 3.0 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
2.9 | 14.7 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
2.9 | 8.8 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
2.9 | 8.8 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
2.9 | 5.9 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
2.9 | 102.9 | GO:0006513 | protein monoubiquitination(GO:0006513) |
2.9 | 8.8 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
2.9 | 20.4 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
2.9 | 14.5 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
2.9 | 20.3 | GO:0002489 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) |
2.9 | 14.5 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
2.9 | 8.7 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
2.9 | 14.4 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
2.9 | 11.5 | GO:0044827 | modulation by host of viral genome replication(GO:0044827) |
2.9 | 5.8 | GO:0010040 | response to iron(II) ion(GO:0010040) |
2.9 | 14.4 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
2.9 | 8.6 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
2.9 | 20.1 | GO:0035372 | protein localization to microtubule(GO:0035372) |
2.9 | 17.1 | GO:0006004 | fucose metabolic process(GO:0006004) |
2.9 | 8.6 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
2.9 | 11.4 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
2.8 | 8.5 | GO:0006007 | glucose catabolic process(GO:0006007) |
2.8 | 28.4 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
2.8 | 19.9 | GO:0046040 | IMP metabolic process(GO:0046040) |
2.8 | 14.2 | GO:0070874 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
2.8 | 8.5 | GO:0015817 | histidine transport(GO:0015817) |
2.8 | 17.0 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
2.8 | 8.5 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
2.8 | 14.2 | GO:2000662 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) regulation of interleukin-13 secretion(GO:2000665) |
2.8 | 33.9 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
2.8 | 5.6 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
2.8 | 36.5 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
2.8 | 2.8 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
2.8 | 8.4 | GO:0034405 | response to fluid shear stress(GO:0034405) |
2.8 | 5.6 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
2.8 | 2.8 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
2.8 | 16.7 | GO:0043173 | nucleotide salvage(GO:0043173) |
2.8 | 13.8 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
2.8 | 22.1 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
2.8 | 8.3 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
2.8 | 8.3 | GO:0046104 | thymidine metabolic process(GO:0046104) |
2.7 | 74.1 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
2.7 | 5.5 | GO:0019042 | viral latency(GO:0019042) |
2.7 | 8.2 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
2.7 | 8.2 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
2.7 | 13.7 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
2.7 | 5.5 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
2.7 | 13.6 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
2.7 | 8.2 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
2.7 | 8.2 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
2.7 | 29.9 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
2.7 | 2.7 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
2.7 | 10.8 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
2.7 | 8.1 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
2.7 | 2.7 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
2.7 | 16.2 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
2.7 | 16.2 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
2.7 | 18.9 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
2.7 | 16.2 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
2.7 | 18.9 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
2.7 | 5.4 | GO:0006600 | creatine metabolic process(GO:0006600) |
2.7 | 8.1 | GO:0080009 | mRNA methylation(GO:0080009) |
2.7 | 2.7 | GO:0034587 | piRNA metabolic process(GO:0034587) |
2.7 | 5.4 | GO:0060544 | regulation of necroptotic process(GO:0060544) negative regulation of necroptotic process(GO:0060546) |
2.7 | 8.1 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
2.7 | 5.4 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
2.7 | 72.4 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
2.7 | 8.0 | GO:0003096 | renal sodium ion transport(GO:0003096) |
2.7 | 2.7 | GO:1904467 | regulation of tumor necrosis factor secretion(GO:1904467) positive regulation of tumor necrosis factor secretion(GO:1904469) tumor necrosis factor secretion(GO:1990774) |
2.7 | 2.7 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
2.7 | 16.0 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
2.7 | 8.0 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
2.7 | 8.0 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
2.7 | 13.3 | GO:0050686 | negative regulation of mRNA processing(GO:0050686) |
2.6 | 7.9 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
2.6 | 10.6 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
2.6 | 23.7 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
2.6 | 2.6 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
2.6 | 5.2 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
2.6 | 34.1 | GO:0006376 | mRNA splice site selection(GO:0006376) |
2.6 | 7.9 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
2.6 | 15.7 | GO:0090166 | Golgi disassembly(GO:0090166) |
2.6 | 7.8 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
2.6 | 7.8 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
2.6 | 2.6 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
2.6 | 12.9 | GO:0061615 | glycolytic process through fructose-6-phosphate(GO:0061615) |
2.6 | 15.5 | GO:0043486 | histone exchange(GO:0043486) |
2.6 | 7.7 | GO:0051409 | response to nitrosative stress(GO:0051409) |
2.6 | 46.1 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
2.6 | 2.6 | GO:0061419 | positive regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061419) |
2.5 | 2.5 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
2.5 | 5.1 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
2.5 | 5.1 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
2.5 | 2.5 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
2.5 | 5.0 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
2.5 | 7.6 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
2.5 | 12.6 | GO:1902669 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
2.5 | 7.5 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
2.5 | 5.0 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
2.5 | 7.5 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
2.5 | 17.5 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
2.5 | 7.5 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
2.5 | 12.5 | GO:1903672 | positive regulation of sprouting angiogenesis(GO:1903672) |
2.5 | 7.5 | GO:0030575 | nuclear body organization(GO:0030575) |
2.5 | 5.0 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
2.5 | 12.5 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
2.5 | 7.5 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
2.5 | 14.9 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
2.5 | 14.9 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
2.5 | 17.3 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
2.5 | 9.9 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
2.5 | 2.5 | GO:0034114 | regulation of heterotypic cell-cell adhesion(GO:0034114) |
2.5 | 27.1 | GO:0043968 | histone H2A acetylation(GO:0043968) |
2.5 | 2.5 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) positive regulation of osteoclast proliferation(GO:0090290) |
2.5 | 4.9 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
2.5 | 9.8 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
2.5 | 24.5 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
2.4 | 7.3 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
2.4 | 7.3 | GO:1900221 | regulation of beta-amyloid clearance(GO:1900221) |
2.4 | 7.3 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
2.4 | 24.3 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
2.4 | 7.3 | GO:0015819 | lysine transport(GO:0015819) |
2.4 | 2.4 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
2.4 | 4.8 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
2.4 | 19.3 | GO:0051198 | negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
2.4 | 4.8 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
2.4 | 24.2 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
2.4 | 4.8 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
2.4 | 9.6 | GO:0036089 | cleavage furrow formation(GO:0036089) |
2.4 | 2.4 | GO:0050779 | RNA destabilization(GO:0050779) |
2.4 | 7.2 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
2.4 | 4.8 | GO:0010212 | response to ionizing radiation(GO:0010212) |
2.4 | 16.8 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
2.4 | 2.4 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
2.4 | 4.8 | GO:0031269 | pseudopodium assembly(GO:0031269) |
2.4 | 4.7 | GO:0018343 | protein farnesylation(GO:0018343) |
2.4 | 11.8 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
2.4 | 14.2 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
2.4 | 9.4 | GO:0015886 | heme transport(GO:0015886) |
2.3 | 30.5 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
2.3 | 28.1 | GO:0014898 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
2.3 | 11.7 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
2.3 | 9.3 | GO:1903147 | negative regulation of mitophagy(GO:1903147) |
2.3 | 13.9 | GO:0060613 | fat pad development(GO:0060613) |
2.3 | 11.6 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
2.3 | 4.6 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
2.3 | 23.0 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
2.3 | 6.9 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
2.3 | 6.9 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
2.3 | 20.7 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
2.3 | 6.9 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
2.3 | 2.3 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
2.3 | 9.2 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
2.3 | 16.1 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
2.3 | 20.6 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
2.3 | 29.7 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
2.3 | 9.1 | GO:0031053 | primary miRNA processing(GO:0031053) |
2.3 | 2.3 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
2.3 | 22.7 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
2.3 | 65.8 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
2.3 | 6.8 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
2.3 | 22.6 | GO:0034204 | lipid translocation(GO:0034204) |
2.2 | 6.7 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
2.2 | 6.7 | GO:0071280 | cellular response to copper ion(GO:0071280) |
2.2 | 4.5 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
2.2 | 9.0 | GO:0072675 | osteoclast fusion(GO:0072675) |
2.2 | 6.7 | GO:0006573 | valine metabolic process(GO:0006573) |
2.2 | 31.4 | GO:0006301 | postreplication repair(GO:0006301) |
2.2 | 2.2 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
2.2 | 22.3 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
2.2 | 4.5 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
2.2 | 4.5 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
2.2 | 6.7 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
2.2 | 20.0 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
2.2 | 8.9 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
2.2 | 6.7 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
2.2 | 2.2 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
2.2 | 4.4 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
2.2 | 8.8 | GO:0046218 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
2.2 | 4.4 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
2.2 | 4.4 | GO:0003072 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
2.2 | 11.0 | GO:0032801 | receptor catabolic process(GO:0032801) |
2.2 | 8.8 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
2.2 | 13.2 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
2.2 | 17.6 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
2.2 | 6.6 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
2.2 | 4.4 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
2.2 | 28.5 | GO:0044783 | mitotic G1 DNA damage checkpoint(GO:0031571) G1 DNA damage checkpoint(GO:0044783) |
2.2 | 4.4 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
2.2 | 13.1 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
2.2 | 2.2 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
2.2 | 10.9 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
2.2 | 4.4 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
2.2 | 2.2 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
2.2 | 97.9 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
2.2 | 6.5 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) |
2.2 | 4.3 | GO:0060057 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
2.2 | 17.3 | GO:0021670 | lateral ventricle development(GO:0021670) |
2.2 | 2.2 | GO:0044532 | modulation of programmed cell death in other organism(GO:0044531) modulation of apoptotic process in other organism(GO:0044532) modulation by symbiont of host programmed cell death(GO:0052040) modulation by symbiont of host apoptotic process(GO:0052150) modulation of programmed cell death in other organism involved in symbiotic interaction(GO:0052248) modulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052433) |
2.2 | 6.5 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
2.2 | 19.4 | GO:0009301 | snRNA transcription(GO:0009301) |
2.2 | 23.7 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
2.2 | 2.2 | GO:0071616 | thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
2.1 | 8.6 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
2.1 | 2.1 | GO:0050904 | diapedesis(GO:0050904) |
2.1 | 10.7 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
2.1 | 6.4 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
2.1 | 19.3 | GO:0038092 | nodal signaling pathway(GO:0038092) |
2.1 | 19.3 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
2.1 | 12.8 | GO:0032782 | bile acid secretion(GO:0032782) |
2.1 | 12.8 | GO:0015858 | nucleoside transport(GO:0015858) |
2.1 | 2.1 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
2.1 | 2.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
2.1 | 2.1 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
2.1 | 42.5 | GO:0016073 | snRNA metabolic process(GO:0016073) |
2.1 | 42.5 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
2.1 | 4.2 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
2.1 | 8.5 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
2.1 | 31.8 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
2.1 | 6.4 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
2.1 | 14.8 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
2.1 | 4.2 | GO:0035973 | aggrephagy(GO:0035973) |
2.1 | 4.2 | GO:0030576 | Cajal body organization(GO:0030576) |
2.1 | 4.2 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
2.1 | 10.5 | GO:0046060 | dATP metabolic process(GO:0046060) |
2.1 | 10.4 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
2.1 | 45.9 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
2.1 | 10.4 | GO:0039529 | RIG-I signaling pathway(GO:0039529) |
2.1 | 2.1 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
2.1 | 4.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
2.1 | 8.3 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
2.1 | 4.1 | GO:0021747 | cochlear nucleus development(GO:0021747) |
2.1 | 10.3 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
2.1 | 4.1 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
2.1 | 4.1 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
2.1 | 2.1 | GO:0006625 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
2.1 | 2.1 | GO:0030242 | pexophagy(GO:0030242) |
2.1 | 12.3 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
2.1 | 4.1 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
2.1 | 12.3 | GO:0046599 | regulation of centriole replication(GO:0046599) |
2.0 | 4.1 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
2.0 | 2.0 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
2.0 | 10.2 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
2.0 | 6.1 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
2.0 | 2.0 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
2.0 | 2.0 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
2.0 | 12.1 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
2.0 | 18.2 | GO:0051383 | kinetochore organization(GO:0051383) |
2.0 | 8.1 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
2.0 | 14.1 | GO:0034508 | centromere complex assembly(GO:0034508) |
2.0 | 2.0 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
2.0 | 14.0 | GO:0071318 | cellular response to ATP(GO:0071318) |
2.0 | 8.0 | GO:0044857 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) |
2.0 | 75.9 | GO:0007569 | cell aging(GO:0007569) |
2.0 | 6.0 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
2.0 | 2.0 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
2.0 | 13.9 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
2.0 | 2.0 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
2.0 | 39.6 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
2.0 | 2.0 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
2.0 | 5.9 | GO:0071223 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
2.0 | 5.9 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
2.0 | 3.9 | GO:1902075 | cellular response to salt(GO:1902075) |
2.0 | 5.9 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
2.0 | 15.7 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
2.0 | 9.8 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
2.0 | 5.9 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
2.0 | 5.9 | GO:0006642 | triglyceride mobilization(GO:0006642) |
1.9 | 3.9 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
1.9 | 5.8 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
1.9 | 5.8 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
1.9 | 5.8 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
1.9 | 1.9 | GO:0046033 | AMP metabolic process(GO:0046033) |
1.9 | 3.9 | GO:0060192 | negative regulation of lipase activity(GO:0060192) |
1.9 | 5.8 | GO:0032439 | endosome localization(GO:0032439) |
1.9 | 7.7 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
1.9 | 5.8 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
1.9 | 7.7 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
1.9 | 3.8 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
1.9 | 7.6 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
1.9 | 3.8 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) |
1.9 | 7.6 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
1.9 | 32.4 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
1.9 | 7.6 | GO:0018101 | protein citrullination(GO:0018101) |
1.9 | 1.9 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) |
1.9 | 15.1 | GO:0008343 | adult feeding behavior(GO:0008343) |
1.9 | 18.8 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
1.9 | 5.7 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
1.9 | 16.9 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
1.9 | 13.1 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
1.9 | 1.9 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
1.9 | 5.6 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
1.9 | 5.6 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
1.9 | 1.9 | GO:0048769 | sarcomerogenesis(GO:0048769) |
1.9 | 7.5 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
1.9 | 3.7 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
1.9 | 5.6 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
1.9 | 20.4 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
1.9 | 3.7 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
1.8 | 1.8 | GO:0036302 | atrioventricular canal development(GO:0036302) |
1.8 | 5.5 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
1.8 | 11.1 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
1.8 | 5.5 | GO:0015705 | iodide transport(GO:0015705) |
1.8 | 9.2 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
1.8 | 16.5 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
1.8 | 3.7 | GO:1902969 | mitotic DNA replication(GO:1902969) |
1.8 | 3.6 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
1.8 | 3.6 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
1.8 | 3.6 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
1.8 | 3.6 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
1.8 | 32.7 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
1.8 | 3.6 | GO:1903376 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
1.8 | 12.6 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
1.8 | 17.9 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
1.8 | 10.7 | GO:0043249 | erythrocyte maturation(GO:0043249) |
1.8 | 39.2 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
1.8 | 3.5 | GO:0046386 | deoxyribose phosphate catabolic process(GO:0046386) |
1.8 | 23.0 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
1.8 | 3.5 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
1.8 | 5.3 | GO:0001866 | NK T cell proliferation(GO:0001866) |
1.8 | 7.1 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
1.8 | 24.7 | GO:0010762 | regulation of fibroblast migration(GO:0010762) |
1.8 | 1.8 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
1.8 | 8.8 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
1.8 | 1.8 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
1.8 | 7.0 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
1.8 | 1.8 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
1.8 | 5.3 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
1.7 | 3.5 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
1.7 | 5.2 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
1.7 | 3.5 | GO:0090559 | regulation of membrane permeability(GO:0090559) |
1.7 | 5.2 | GO:0006057 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
1.7 | 7.0 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
1.7 | 1.7 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
1.7 | 3.5 | GO:0048289 | isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) |
1.7 | 12.2 | GO:0071696 | ectodermal placode formation(GO:0060788) ectodermal placode development(GO:0071696) ectodermal placode morphogenesis(GO:0071697) |
1.7 | 13.9 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
1.7 | 1.7 | GO:0043379 | memory T cell differentiation(GO:0043379) |
1.7 | 15.6 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
1.7 | 41.5 | GO:0043966 | histone H3 acetylation(GO:0043966) |
1.7 | 1.7 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
1.7 | 10.4 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
1.7 | 1.7 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
1.7 | 6.9 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
1.7 | 31.0 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
1.7 | 1.7 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
1.7 | 6.9 | GO:0090527 | actin filament reorganization(GO:0090527) |
1.7 | 1.7 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
1.7 | 1.7 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
1.7 | 25.7 | GO:0016575 | histone deacetylation(GO:0016575) |
1.7 | 12.0 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
1.7 | 3.4 | GO:1901563 | response to camptothecin(GO:1901563) |
1.7 | 3.4 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
1.7 | 1.7 | GO:0003162 | atrioventricular node development(GO:0003162) |
1.7 | 3.4 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
1.7 | 5.1 | GO:0000052 | citrulline metabolic process(GO:0000052) |
1.7 | 5.1 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
1.7 | 8.5 | GO:0017014 | protein nitrosylation(GO:0017014) |
1.7 | 11.9 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
1.7 | 13.6 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
1.7 | 8.5 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
1.7 | 3.4 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
1.7 | 18.6 | GO:0035493 | SNARE complex assembly(GO:0035493) |
1.7 | 3.4 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
1.7 | 6.8 | GO:0000212 | meiotic spindle organization(GO:0000212) |
1.7 | 5.1 | GO:0048478 | replication fork protection(GO:0048478) |
1.7 | 5.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
1.7 | 8.4 | GO:0006561 | proline biosynthetic process(GO:0006561) |
1.7 | 1.7 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
1.7 | 1.7 | GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
1.7 | 3.4 | GO:0042993 | positive regulation of transcription factor import into nucleus(GO:0042993) |
1.7 | 1.7 | GO:0051657 | maintenance of organelle location(GO:0051657) |
1.7 | 6.7 | GO:0046831 | regulation of nucleobase-containing compound transport(GO:0032239) regulation of RNA export from nucleus(GO:0046831) |
1.7 | 15.0 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
1.7 | 8.3 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
1.7 | 15.0 | GO:0046686 | response to cadmium ion(GO:0046686) |
1.7 | 36.5 | GO:0006338 | chromatin remodeling(GO:0006338) |
1.7 | 5.0 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
1.7 | 10.0 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
1.7 | 1.7 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
1.7 | 14.9 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
1.7 | 5.0 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.7 | 5.0 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
1.7 | 21.5 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
1.7 | 1.7 | GO:2000650 | negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
1.7 | 5.0 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
1.6 | 16.4 | GO:0050820 | positive regulation of coagulation(GO:0050820) |
1.6 | 6.6 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
1.6 | 6.6 | GO:0033194 | response to hydroperoxide(GO:0033194) |
1.6 | 6.6 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
1.6 | 4.9 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
1.6 | 4.9 | GO:0044773 | mitotic DNA damage checkpoint(GO:0044773) |
1.6 | 8.2 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
1.6 | 6.5 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
1.6 | 3.3 | GO:0060215 | primitive hemopoiesis(GO:0060215) |
1.6 | 9.8 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
1.6 | 8.1 | GO:0070475 | rRNA base methylation(GO:0070475) |
1.6 | 3.2 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
1.6 | 8.1 | GO:0031167 | rRNA methylation(GO:0031167) |
1.6 | 3.2 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
1.6 | 6.5 | GO:0006824 | cobalt ion transport(GO:0006824) |
1.6 | 4.8 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
1.6 | 19.4 | GO:0042730 | fibrinolysis(GO:0042730) |
1.6 | 3.2 | GO:0044351 | macropinocytosis(GO:0044351) |
1.6 | 14.5 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
1.6 | 22.5 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
1.6 | 1.6 | GO:0060268 | respiratory burst involved in inflammatory response(GO:0002536) regulation of respiratory burst involved in inflammatory response(GO:0060264) negative regulation of respiratory burst involved in inflammatory response(GO:0060266) negative regulation of respiratory burst(GO:0060268) |
1.6 | 4.8 | GO:0043174 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) nucleoside salvage(GO:0043174) |
1.6 | 1.6 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
1.6 | 1.6 | GO:0044088 | regulation of vacuole organization(GO:0044088) |
1.6 | 6.4 | GO:0007000 | nucleolus organization(GO:0007000) |
1.6 | 33.5 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
1.6 | 3.2 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
1.6 | 8.0 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
1.6 | 4.8 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
1.6 | 6.4 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
1.6 | 4.8 | GO:0042168 | heme metabolic process(GO:0042168) |
1.6 | 6.4 | GO:0036035 | osteoclast development(GO:0036035) |
1.6 | 1.6 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
1.6 | 7.9 | GO:0002576 | platelet degranulation(GO:0002576) |
1.6 | 4.8 | GO:0061515 | myeloid cell development(GO:0061515) |
1.6 | 7.9 | GO:2000352 | negative regulation of endothelial cell apoptotic process(GO:2000352) |
1.6 | 1.6 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
1.6 | 3.2 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
1.6 | 4.7 | GO:0044786 | cell cycle DNA replication(GO:0044786) |
1.6 | 9.4 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
1.6 | 3.1 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
1.6 | 4.7 | GO:0009838 | abscission(GO:0009838) |
1.6 | 4.7 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
1.5 | 1.5 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
1.5 | 3.1 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
1.5 | 13.9 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
1.5 | 6.2 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
1.5 | 9.2 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
1.5 | 12.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
1.5 | 10.7 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
1.5 | 10.7 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
1.5 | 13.8 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
1.5 | 6.1 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
1.5 | 52.1 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
1.5 | 3.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
1.5 | 6.1 | GO:0002249 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
1.5 | 4.6 | GO:0048069 | eye pigmentation(GO:0048069) |
1.5 | 9.2 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
1.5 | 4.6 | GO:0015744 | succinate transport(GO:0015744) |
1.5 | 4.6 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
1.5 | 16.7 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
1.5 | 15.2 | GO:0051601 | exocyst localization(GO:0051601) |
1.5 | 3.0 | GO:0000237 | leptotene(GO:0000237) |
1.5 | 3.0 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
1.5 | 6.0 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
1.5 | 6.0 | GO:0019695 | choline metabolic process(GO:0019695) |
1.5 | 6.0 | GO:1900193 | regulation of oocyte maturation(GO:1900193) |
1.5 | 15.0 | GO:0042407 | cristae formation(GO:0042407) |
1.5 | 1.5 | GO:0021590 | cerebellum maturation(GO:0021590) |
1.5 | 1.5 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
1.5 | 16.5 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
1.5 | 37.3 | GO:0071806 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
1.5 | 44.6 | GO:0071824 | protein-DNA complex subunit organization(GO:0071824) |
1.5 | 8.9 | GO:0070327 | thyroid hormone transport(GO:0070327) |
1.5 | 3.0 | GO:0033227 | dsRNA transport(GO:0033227) |
1.5 | 7.4 | GO:0071711 | basement membrane organization(GO:0071711) |
1.5 | 1.5 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
1.5 | 1.5 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
1.5 | 7.3 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
1.5 | 4.4 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
1.5 | 7.3 | GO:0032648 | regulation of interferon-beta production(GO:0032648) |
1.5 | 4.4 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
1.5 | 1.5 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
1.4 | 10.1 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
1.4 | 2.9 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
1.4 | 4.3 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
1.4 | 13.0 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
1.4 | 1.4 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
1.4 | 5.7 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
1.4 | 7.1 | GO:0009437 | carnitine metabolic process(GO:0009437) |
1.4 | 1.4 | GO:0009074 | aromatic amino acid family catabolic process(GO:0009074) |
1.4 | 1.4 | GO:0002645 | positive regulation of tolerance induction(GO:0002645) |
1.4 | 1.4 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
1.4 | 1.4 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
1.4 | 4.3 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
1.4 | 25.6 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
1.4 | 19.9 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
1.4 | 9.9 | GO:0035855 | megakaryocyte development(GO:0035855) |
1.4 | 2.8 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
1.4 | 4.2 | GO:0000467 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
1.4 | 1.4 | GO:0009264 | deoxyribonucleotide catabolic process(GO:0009264) |
1.4 | 15.5 | GO:0001675 | acrosome assembly(GO:0001675) |
1.4 | 5.6 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
1.4 | 2.8 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
1.4 | 2.8 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
1.4 | 1.4 | GO:0015684 | ferrous iron transport(GO:0015684) |
1.4 | 2.8 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
1.4 | 5.6 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
1.4 | 1.4 | GO:0007619 | courtship behavior(GO:0007619) |
1.4 | 2.8 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
1.4 | 1.4 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
1.4 | 2.7 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
1.4 | 1.4 | GO:2001267 | regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001267) |
1.4 | 4.1 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
1.4 | 4.1 | GO:0098535 | de novo centriole assembly(GO:0098535) |
1.4 | 1.4 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
1.4 | 8.2 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
1.4 | 21.8 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
1.4 | 1.4 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
1.4 | 4.1 | GO:2001252 | positive regulation of chromosome organization(GO:2001252) |
1.3 | 6.7 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
1.3 | 8.1 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
1.3 | 6.7 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
1.3 | 1.3 | GO:0006999 | nuclear pore organization(GO:0006999) |
1.3 | 1.3 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
1.3 | 5.3 | GO:0030202 | heparin metabolic process(GO:0030202) |
1.3 | 4.0 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
1.3 | 8.0 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
1.3 | 5.3 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
1.3 | 6.6 | GO:0051026 | chiasma assembly(GO:0051026) |
1.3 | 4.0 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
1.3 | 4.0 | GO:0045402 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
1.3 | 2.6 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
1.3 | 1.3 | GO:0002190 | cap-independent translational initiation(GO:0002190) |
1.3 | 6.6 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
1.3 | 6.6 | GO:0042026 | protein refolding(GO:0042026) |
1.3 | 1.3 | GO:0044774 | mitotic DNA integrity checkpoint(GO:0044774) |
1.3 | 1.3 | GO:0071028 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
1.3 | 1.3 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
1.3 | 11.8 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
1.3 | 6.5 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
1.3 | 1.3 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) |
1.3 | 3.9 | GO:0016264 | gap junction assembly(GO:0016264) |
1.3 | 7.8 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
1.3 | 20.8 | GO:1904029 | regulation of cyclin-dependent protein kinase activity(GO:1904029) |
1.3 | 42.9 | GO:0006611 | protein export from nucleus(GO:0006611) |
1.3 | 23.4 | GO:0033048 | negative regulation of mitotic sister chromatid segregation(GO:0033048) |
1.3 | 37.6 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
1.3 | 2.6 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
1.3 | 2.6 | GO:0006116 | NADH oxidation(GO:0006116) |
1.3 | 2.6 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
1.3 | 2.6 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
1.3 | 20.5 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
1.3 | 3.8 | GO:1901889 | negative regulation of cell junction assembly(GO:1901889) |
1.3 | 1.3 | GO:0071450 | cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
1.3 | 1.3 | GO:0051036 | regulation of endosome size(GO:0051036) |
1.3 | 2.5 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
1.3 | 2.5 | GO:0034214 | protein hexamerization(GO:0034214) |
1.3 | 5.1 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
1.3 | 3.8 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
1.3 | 3.8 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
1.3 | 3.8 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
1.3 | 2.5 | GO:0015793 | glycerol transport(GO:0015793) |
1.3 | 6.3 | GO:0032099 | negative regulation of appetite(GO:0032099) |
1.3 | 1.3 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
1.3 | 3.8 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
1.3 | 3.8 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
1.3 | 1.3 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
1.3 | 3.8 | GO:0008089 | anterograde axonal transport(GO:0008089) |
1.3 | 12.5 | GO:0031648 | protein destabilization(GO:0031648) |
1.3 | 3.8 | GO:0033572 | transferrin transport(GO:0033572) |
1.2 | 3.7 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
1.2 | 6.2 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
1.2 | 2.5 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
1.2 | 6.2 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
1.2 | 36.0 | GO:0007030 | Golgi organization(GO:0007030) |
1.2 | 1.2 | GO:0016572 | histone phosphorylation(GO:0016572) |
1.2 | 32.2 | GO:0006749 | glutathione metabolic process(GO:0006749) |
1.2 | 2.5 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
1.2 | 14.9 | GO:0016925 | protein sumoylation(GO:0016925) |
1.2 | 4.9 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
1.2 | 2.5 | GO:1902218 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
1.2 | 12.3 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
1.2 | 9.8 | GO:0001893 | maternal placenta development(GO:0001893) |
1.2 | 6.1 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
1.2 | 3.7 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
1.2 | 3.7 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
1.2 | 9.7 | GO:0007097 | nuclear migration(GO:0007097) |
1.2 | 6.1 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
1.2 | 1.2 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
1.2 | 1.2 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
1.2 | 2.4 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
1.2 | 7.3 | GO:0006013 | mannose metabolic process(GO:0006013) |
1.2 | 2.4 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
1.2 | 4.8 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
1.2 | 7.2 | GO:0010664 | negative regulation of striated muscle cell apoptotic process(GO:0010664) |
1.2 | 1.2 | GO:0006106 | fumarate metabolic process(GO:0006106) |
1.2 | 3.6 | GO:0006907 | pinocytosis(GO:0006907) |
1.2 | 2.4 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
1.2 | 22.7 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
1.2 | 4.8 | GO:1902414 | protein localization to cell junction(GO:1902414) |
1.2 | 6.0 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
1.2 | 1.2 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
1.2 | 4.8 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
1.2 | 9.5 | GO:0072520 | seminiferous tubule development(GO:0072520) |
1.2 | 2.4 | GO:0060920 | cardiac pacemaker cell differentiation(GO:0060920) sinoatrial node cell differentiation(GO:0060921) |
1.2 | 1.2 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
1.2 | 20.1 | GO:0051865 | protein autoubiquitination(GO:0051865) |
1.2 | 13.0 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
1.2 | 3.5 | GO:0031054 | pre-miRNA processing(GO:0031054) |
1.2 | 1.2 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
1.2 | 5.9 | GO:0032310 | prostaglandin secretion(GO:0032310) |
1.2 | 4.7 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
1.2 | 2.4 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
1.2 | 17.6 | GO:0051310 | metaphase plate congression(GO:0051310) |
1.2 | 5.9 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
1.2 | 2.3 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
1.2 | 2.3 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
1.2 | 2.3 | GO:0046174 | polyol catabolic process(GO:0046174) |
1.2 | 1.2 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
1.2 | 2.3 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
1.2 | 2.3 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
1.2 | 1.2 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
1.2 | 5.8 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
1.1 | 9.2 | GO:0009303 | rRNA transcription(GO:0009303) |
1.1 | 4.6 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
1.1 | 48.0 | GO:0009142 | nucleoside triphosphate biosynthetic process(GO:0009142) |
1.1 | 1.1 | GO:0071166 | ribonucleoprotein complex localization(GO:0071166) |
1.1 | 2.3 | GO:0034143 | regulation of toll-like receptor 4 signaling pathway(GO:0034143) |
1.1 | 3.4 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) late endosome to vacuole transport(GO:0045324) |
1.1 | 18.2 | GO:0051168 | nuclear export(GO:0051168) |
1.1 | 3.4 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
1.1 | 9.0 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
1.1 | 2.2 | GO:0006991 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
1.1 | 6.7 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
1.1 | 2.2 | GO:0002892 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
1.1 | 11.1 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
1.1 | 2.2 | GO:0045047 | protein targeting to ER(GO:0045047) |
1.1 | 3.3 | GO:0009992 | cellular water homeostasis(GO:0009992) |
1.1 | 2.2 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
1.1 | 3.3 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
1.1 | 7.7 | GO:0046039 | GTP metabolic process(GO:0046039) |
1.1 | 1.1 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
1.1 | 5.5 | GO:0042448 | progesterone metabolic process(GO:0042448) |
1.1 | 12.0 | GO:0060612 | adipose tissue development(GO:0060612) |
1.1 | 6.6 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
1.1 | 2.2 | GO:0051255 | spindle midzone assembly(GO:0051255) |
1.1 | 20.6 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
1.1 | 3.2 | GO:0007028 | cytoplasm organization(GO:0007028) |
1.1 | 1.1 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
1.1 | 10.8 | GO:1901739 | regulation of myoblast fusion(GO:1901739) positive regulation of myoblast fusion(GO:1901741) |
1.1 | 4.3 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
1.1 | 5.4 | GO:0010829 | negative regulation of glucose transport(GO:0010829) |
1.1 | 2.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
1.1 | 3.2 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
1.1 | 1.1 | GO:0048382 | mesendoderm development(GO:0048382) |
1.1 | 1.1 | GO:0051775 | response to redox state(GO:0051775) |
1.1 | 3.2 | GO:0060155 | platelet dense granule organization(GO:0060155) |
1.1 | 1.1 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
1.1 | 3.2 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) |
1.1 | 2.1 | GO:0070914 | UV-damage excision repair(GO:0070914) |
1.1 | 2.1 | GO:0048143 | astrocyte activation(GO:0048143) |
1.1 | 41.2 | GO:0051028 | mRNA transport(GO:0051028) |
1.1 | 10.6 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
1.1 | 4.2 | GO:0015670 | carbon dioxide transport(GO:0015670) |
1.1 | 4.2 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
1.1 | 1.1 | GO:0042891 | antibiotic transport(GO:0042891) |
1.0 | 8.4 | GO:0006278 | RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
1.0 | 3.1 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
1.0 | 8.3 | GO:0051014 | actin filament severing(GO:0051014) |
1.0 | 2.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
1.0 | 5.2 | GO:2000351 | regulation of endothelial cell apoptotic process(GO:2000351) |
1.0 | 1.0 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
1.0 | 8.3 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
1.0 | 3.1 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
1.0 | 2.1 | GO:0070199 | establishment of protein localization to chromosome(GO:0070199) |
1.0 | 2.1 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
1.0 | 9.3 | GO:0070265 | necrotic cell death(GO:0070265) |
1.0 | 1.0 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
1.0 | 7.2 | GO:0043248 | proteasome assembly(GO:0043248) |
1.0 | 3.1 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
1.0 | 5.1 | GO:0030261 | chromosome condensation(GO:0030261) |
1.0 | 6.2 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
1.0 | 5.1 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
1.0 | 20.5 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
1.0 | 7.2 | GO:0097345 | mitochondrial outer membrane permeabilization(GO:0097345) |
1.0 | 2.0 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
1.0 | 3.0 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.0 | 2.0 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
1.0 | 3.0 | GO:0035729 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
1.0 | 10.1 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
1.0 | 12.2 | GO:0030149 | sphingolipid catabolic process(GO:0030149) |
1.0 | 4.0 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
1.0 | 29.3 | GO:0045454 | cell redox homeostasis(GO:0045454) |
1.0 | 1.0 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
1.0 | 1.0 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
1.0 | 6.0 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
1.0 | 1.0 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
1.0 | 1.0 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
1.0 | 1.0 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
1.0 | 30.8 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
1.0 | 2.0 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
1.0 | 1.0 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
1.0 | 2.0 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
1.0 | 1.0 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
1.0 | 2.0 | GO:0042574 | retinal metabolic process(GO:0042574) |
1.0 | 2.0 | GO:0006984 | ER-nucleus signaling pathway(GO:0006984) |
1.0 | 1.0 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
1.0 | 3.9 | GO:0016576 | histone dephosphorylation(GO:0016576) |
1.0 | 39.3 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
1.0 | 1.0 | GO:0031047 | gene silencing by RNA(GO:0031047) |
1.0 | 2.0 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
1.0 | 1.0 | GO:0031627 | telomeric loop formation(GO:0031627) |
1.0 | 7.8 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
1.0 | 23.5 | GO:0042073 | intraciliary transport(GO:0042073) |
1.0 | 2.0 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
1.0 | 14.6 | GO:0032873 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
1.0 | 9.8 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
1.0 | 4.9 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
1.0 | 3.9 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
1.0 | 9.7 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
1.0 | 8.7 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
1.0 | 2.9 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
1.0 | 1.0 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
1.0 | 2.9 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
1.0 | 6.8 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
1.0 | 1.0 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
1.0 | 6.7 | GO:0007379 | segment specification(GO:0007379) |
1.0 | 5.8 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
1.0 | 5.7 | GO:0002467 | germinal center formation(GO:0002467) |
1.0 | 1.9 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
1.0 | 1.0 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.9 | 1.9 | GO:0009299 | mRNA transcription(GO:0009299) |
0.9 | 8.5 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.9 | 3.8 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.9 | 3.8 | GO:0045738 | negative regulation of DNA repair(GO:0045738) |
0.9 | 0.9 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.9 | 5.6 | GO:0000338 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.9 | 0.9 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.9 | 6.5 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.9 | 0.9 | GO:0072527 | pyrimidine-containing compound metabolic process(GO:0072527) |
0.9 | 5.6 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.9 | 19.5 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.9 | 1.9 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.9 | 2.8 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.9 | 70.4 | GO:0016568 | chromatin modification(GO:0016568) |
0.9 | 4.6 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.9 | 7.4 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.9 | 35.1 | GO:0051297 | centrosome organization(GO:0051297) |
0.9 | 1.8 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.9 | 11.1 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.9 | 3.7 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.9 | 1.8 | GO:0031033 | myosin filament organization(GO:0031033) |
0.9 | 12.0 | GO:0071901 | negative regulation of protein serine/threonine kinase activity(GO:0071901) |
0.9 | 1.8 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.9 | 5.5 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.9 | 11.0 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.9 | 2.7 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.9 | 3.7 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
0.9 | 1.8 | GO:0008228 | opsonization(GO:0008228) |
0.9 | 1.8 | GO:0051985 | negative regulation of chromosome segregation(GO:0051985) |
0.9 | 1.8 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.9 | 5.5 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.9 | 10.0 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.9 | 6.3 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.9 | 0.9 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.9 | 2.7 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
0.9 | 19.0 | GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process(GO:0043161) |
0.9 | 2.7 | GO:0046131 | pyrimidine ribonucleoside metabolic process(GO:0046131) |
0.9 | 1.8 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.9 | 0.9 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.9 | 2.7 | GO:0006903 | vesicle targeting(GO:0006903) |
0.9 | 2.7 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.9 | 20.7 | GO:0006641 | triglyceride metabolic process(GO:0006641) |
0.9 | 1.8 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.9 | 9.0 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.9 | 8.1 | GO:0043620 | regulation of DNA-templated transcription in response to stress(GO:0043620) |
0.9 | 0.9 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.9 | 12.5 | GO:0006284 | base-excision repair(GO:0006284) |
0.9 | 1.8 | GO:0010225 | response to UV-C(GO:0010225) |
0.9 | 0.9 | GO:0032105 | negative regulation of response to extracellular stimulus(GO:0032105) negative regulation of response to nutrient levels(GO:0032108) |
0.9 | 42.2 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.9 | 0.9 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.9 | 7.0 | GO:0030826 | regulation of cGMP biosynthetic process(GO:0030826) |
0.9 | 0.9 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
0.9 | 0.9 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.9 | 0.9 | GO:0032095 | regulation of response to food(GO:0032095) |
0.9 | 46.8 | GO:0006457 | protein folding(GO:0006457) |
0.9 | 1.7 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.9 | 2.6 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.9 | 1.7 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.9 | 4.3 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.9 | 3.4 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.8 | 0.8 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.8 | 23.7 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.8 | 18.6 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.8 | 3.4 | GO:0032570 | response to progesterone(GO:0032570) |
0.8 | 3.4 | GO:0046415 | urate metabolic process(GO:0046415) |
0.8 | 8.3 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.8 | 3.3 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.8 | 1.7 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.8 | 25.6 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.8 | 8.2 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.8 | 12.3 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.8 | 0.8 | GO:0001812 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) positive regulation of type I hypersensitivity(GO:0001812) |
0.8 | 7.3 | GO:0007032 | endosome organization(GO:0007032) |
0.8 | 0.8 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.8 | 4.0 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.8 | 0.8 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.8 | 7.3 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.8 | 5.6 | GO:0016926 | protein desumoylation(GO:0016926) |
0.8 | 17.7 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
0.8 | 1.6 | GO:0031023 | microtubule organizing center organization(GO:0031023) |
0.8 | 1.6 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.8 | 4.8 | GO:0051782 | negative regulation of cell division(GO:0051782) |
0.8 | 2.4 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.8 | 7.9 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.8 | 0.8 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.8 | 2.4 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.8 | 3.1 | GO:0055094 | response to lipoprotein particle(GO:0055094) |
0.8 | 4.7 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.8 | 6.2 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.8 | 4.7 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.8 | 3.1 | GO:2001021 | negative regulation of response to DNA damage stimulus(GO:2001021) |
0.8 | 2.3 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.8 | 2.3 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.8 | 0.8 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.8 | 3.1 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.8 | 1.5 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
0.8 | 4.6 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.8 | 6.8 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.8 | 3.0 | GO:0015871 | choline transport(GO:0015871) |
0.8 | 8.3 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.8 | 9.0 | GO:0050821 | protein stabilization(GO:0050821) |
0.7 | 0.7 | GO:0002724 | T cell cytokine production(GO:0002369) regulation of T cell cytokine production(GO:0002724) |
0.7 | 1.5 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.7 | 18.5 | GO:0055088 | lipid homeostasis(GO:0055088) |
0.7 | 3.7 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.7 | 1.5 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.7 | 33.9 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.7 | 2.9 | GO:0048193 | Golgi vesicle transport(GO:0048193) |
0.7 | 5.1 | GO:0032438 | melanosome organization(GO:0032438) |
0.7 | 4.4 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.7 | 2.2 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.7 | 8.0 | GO:0014850 | response to muscle activity(GO:0014850) |
0.7 | 0.7 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.7 | 17.3 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
0.7 | 2.9 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.7 | 10.1 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.7 | 2.2 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.7 | 2.9 | GO:0036233 | glycine import(GO:0036233) |
0.7 | 1.4 | GO:0072537 | fibroblast activation(GO:0072537) |
0.7 | 0.7 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.7 | 2.1 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.7 | 2.1 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.7 | 0.7 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.7 | 3.5 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.7 | 2.8 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.7 | 4.2 | GO:0051905 | establishment of pigment granule localization(GO:0051905) |
0.7 | 0.7 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.7 | 1.4 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.7 | 14.1 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.7 | 2.1 | GO:0010955 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.7 | 14.7 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.7 | 4.9 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.7 | 2.1 | GO:0000012 | single strand break repair(GO:0000012) |
0.7 | 6.3 | GO:1902850 | mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
0.7 | 2.8 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.7 | 0.7 | GO:1903543 | regulation of exosomal secretion(GO:1903541) positive regulation of exosomal secretion(GO:1903543) |
0.7 | 0.7 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.7 | 8.3 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.7 | 1.4 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.7 | 2.8 | GO:0000154 | rRNA modification(GO:0000154) |
0.7 | 2.1 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.7 | 2.1 | GO:0015888 | thiamine transport(GO:0015888) |
0.7 | 13.0 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.7 | 0.7 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.7 | 4.1 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
0.7 | 2.0 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.7 | 4.1 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.7 | 12.1 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.7 | 4.7 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.7 | 0.7 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.7 | 14.0 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.7 | 1.3 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.7 | 1.3 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.7 | 1.3 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.7 | 1.3 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.7 | 7.9 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.7 | 0.7 | GO:0015791 | polyol transport(GO:0015791) |
0.6 | 2.6 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.6 | 0.6 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.6 | 1.3 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.6 | 18.7 | GO:0043039 | tRNA aminoacylation for protein translation(GO:0006418) tRNA aminoacylation(GO:0043039) |
0.6 | 7.6 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.6 | 1.3 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.6 | 22.8 | GO:1903955 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.6 | 2.5 | GO:0009642 | response to light intensity(GO:0009642) |
0.6 | 2.5 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.6 | 0.6 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.6 | 0.6 | GO:0010165 | response to X-ray(GO:0010165) |
0.6 | 3.1 | GO:0006414 | translational elongation(GO:0006414) |
0.6 | 0.6 | GO:0040033 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.6 | 17.6 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.6 | 10.6 | GO:0005977 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
0.6 | 1.2 | GO:1901068 | guanosine-containing compound metabolic process(GO:1901068) |
0.6 | 12.5 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.6 | 0.6 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.6 | 0.6 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.6 | 3.7 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.6 | 1.9 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.6 | 1.9 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
0.6 | 0.6 | GO:1902221 | L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
0.6 | 1.8 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.6 | 0.6 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.6 | 1.8 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.6 | 6.7 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.6 | 13.4 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.6 | 0.6 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.6 | 0.6 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.6 | 0.6 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.6 | 0.6 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.6 | 0.6 | GO:0044027 | maintenance of DNA methylation(GO:0010216) DNA hypermethylation(GO:0044026) hypermethylation of CpG island(GO:0044027) |
0.6 | 6.0 | GO:1901998 | toxin transport(GO:1901998) |
0.6 | 1.8 | GO:0006839 | mitochondrial transport(GO:0006839) |
0.6 | 3.0 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.6 | 7.1 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.6 | 3.0 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.6 | 10.1 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.6 | 0.6 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.6 | 1.2 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.6 | 0.6 | GO:0071332 | response to fructose(GO:0009750) cellular response to fructose stimulus(GO:0071332) |
0.6 | 4.1 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.6 | 1.2 | GO:0000723 | telomere maintenance(GO:0000723) telomere organization(GO:0032200) |
0.6 | 6.4 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.6 | 2.9 | GO:0006479 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
0.6 | 1.2 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.6 | 0.6 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.6 | 1.1 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.6 | 4.0 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.6 | 0.6 | GO:1903364 | positive regulation of cellular protein catabolic process(GO:1903364) |
0.6 | 2.3 | GO:0015825 | L-serine transport(GO:0015825) |
0.6 | 1.1 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.6 | 2.8 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.6 | 2.8 | GO:0007031 | peroxisome organization(GO:0007031) |
0.6 | 0.6 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.6 | 1.7 | GO:0006448 | regulation of translational elongation(GO:0006448) |
0.6 | 10.6 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.6 | 1.1 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.6 | 4.5 | GO:0071800 | podosome assembly(GO:0071800) |
0.6 | 2.8 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.6 | 1.1 | GO:0006482 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.6 | 0.6 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.5 | 4.4 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.5 | 10.4 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.5 | 2.2 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.5 | 0.5 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.5 | 1.1 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.5 | 1.1 | GO:0002215 | defense response to nematode(GO:0002215) |
0.5 | 2.2 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.5 | 16.1 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) |
0.5 | 1.1 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.5 | 1.1 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.5 | 2.1 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.5 | 1.1 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.5 | 2.1 | GO:0033013 | tetrapyrrole metabolic process(GO:0033013) |
0.5 | 0.5 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.5 | 67.3 | GO:0008380 | RNA splicing(GO:0008380) |
0.5 | 9.3 | GO:0006413 | translational initiation(GO:0006413) |
0.5 | 6.2 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.5 | 0.5 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.5 | 2.1 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.5 | 3.6 | GO:0010498 | proteasomal protein catabolic process(GO:0010498) |
0.5 | 0.5 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
0.5 | 2.5 | GO:0001556 | oocyte maturation(GO:0001556) |
0.5 | 1.5 | GO:0006525 | arginine metabolic process(GO:0006525) |
0.5 | 2.5 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.5 | 2.0 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.5 | 0.5 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.5 | 0.5 | GO:1904238 | pericyte cell differentiation(GO:1904238) |
0.5 | 1.5 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.5 | 1.5 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.5 | 1.0 | GO:0019395 | fatty acid oxidation(GO:0019395) |
0.5 | 1.5 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
0.5 | 9.3 | GO:0019835 | cytolysis(GO:0019835) |
0.5 | 1.5 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.5 | 3.9 | GO:0072350 | tricarboxylic acid metabolic process(GO:0072350) |
0.5 | 3.4 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.5 | 24.3 | GO:0008033 | tRNA processing(GO:0008033) |
0.5 | 0.5 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
0.5 | 6.8 | GO:0006491 | N-glycan processing(GO:0006491) |
0.5 | 1.4 | GO:0000272 | polysaccharide catabolic process(GO:0000272) |
0.5 | 2.9 | GO:1901224 | positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.5 | 1.4 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.5 | 0.9 | GO:0060055 | angiogenesis involved in wound healing(GO:0060055) |
0.5 | 3.3 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.5 | 2.4 | GO:0042756 | drinking behavior(GO:0042756) |
0.5 | 59.1 | GO:0016567 | protein ubiquitination(GO:0016567) |
0.5 | 3.7 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.5 | 0.5 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.5 | 0.9 | GO:0006833 | water transport(GO:0006833) |
0.5 | 0.5 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.5 | 3.2 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.5 | 0.9 | GO:0019377 | glycolipid catabolic process(GO:0019377) |
0.5 | 0.5 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.5 | 5.9 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
0.5 | 0.9 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.5 | 0.5 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.4 | 0.4 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) |
0.4 | 0.4 | GO:2000573 | positive regulation of DNA biosynthetic process(GO:2000573) |
0.4 | 2.2 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.4 | 1.3 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.4 | 8.8 | GO:0006974 | cellular response to DNA damage stimulus(GO:0006974) |
0.4 | 6.6 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.4 | 0.4 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.4 | 0.9 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.4 | 0.4 | GO:0009946 | proximal/distal axis specification(GO:0009946) specification of axis polarity(GO:0065001) |
0.4 | 0.4 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.4 | 0.9 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.4 | 0.4 | GO:0051236 | establishment of RNA localization(GO:0051236) |
0.4 | 1.7 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.4 | 2.1 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.4 | 2.9 | GO:0051881 | regulation of mitochondrial membrane potential(GO:0051881) |
0.4 | 5.0 | GO:0000045 | autophagosome assembly(GO:0000045) |
0.4 | 1.3 | GO:0030638 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.4 | 1.7 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.4 | 5.4 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.4 | 12.4 | GO:0006970 | response to osmotic stress(GO:0006970) |
0.4 | 1.2 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.4 | 0.4 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
0.4 | 6.8 | GO:0006006 | glucose metabolic process(GO:0006006) |
0.4 | 4.8 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.4 | 0.8 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.4 | 2.0 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.4 | 1.2 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.4 | 0.8 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.4 | 1.9 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.4 | 0.4 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.4 | 0.8 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.4 | 2.3 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.4 | 1.9 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.4 | 3.8 | GO:0046364 | monosaccharide biosynthetic process(GO:0046364) |
0.4 | 0.4 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.4 | 0.4 | GO:0007228 | signal transduction downstream of smoothened(GO:0007227) positive regulation of hh target transcription factor activity(GO:0007228) |
0.4 | 1.1 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.4 | 0.7 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.4 | 5.4 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.4 | 0.4 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.4 | 1.1 | GO:0014823 | response to activity(GO:0014823) |
0.4 | 1.1 | GO:0031647 | regulation of protein stability(GO:0031647) |
0.4 | 1.1 | GO:0015671 | oxygen transport(GO:0015671) |
0.4 | 0.4 | GO:0033280 | response to vitamin D(GO:0033280) |
0.4 | 1.1 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.4 | 1.4 | GO:0002251 | organ or tissue specific immune response(GO:0002251) |
0.4 | 3.2 | GO:0008209 | androgen metabolic process(GO:0008209) |
0.4 | 0.4 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.3 | 0.3 | GO:0006206 | pyrimidine nucleobase metabolic process(GO:0006206) |
0.3 | 0.7 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.3 | 2.0 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.3 | 2.4 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.3 | 0.3 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.3 | 0.3 | GO:1990542 | mitochondrial transmembrane transport(GO:1990542) |
0.3 | 2.7 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.3 | 0.7 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.3 | 1.0 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.3 | 1.0 | GO:0090305 | nucleic acid phosphodiester bond hydrolysis(GO:0090305) |
0.3 | 1.0 | GO:0010039 | response to iron ion(GO:0010039) |
0.3 | 0.7 | GO:0032446 | protein modification by small protein conjugation(GO:0032446) |
0.3 | 0.3 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.3 | 0.7 | GO:0006401 | RNA catabolic process(GO:0006401) |
0.3 | 2.0 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.3 | 3.9 | GO:0006626 | protein targeting to mitochondrion(GO:0006626) |
0.3 | 7.8 | GO:0007059 | chromosome segregation(GO:0007059) |
0.3 | 1.0 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.3 | 6.5 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
0.3 | 1.3 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.3 | 0.3 | GO:0097709 | wound healing involved in inflammatory response(GO:0002246) connective tissue replacement involved in inflammatory response wound healing(GO:0002248) inflammatory response to wounding(GO:0090594) connective tissue replacement(GO:0097709) |
0.3 | 0.3 | GO:0034381 | plasma lipoprotein particle clearance(GO:0034381) |
0.3 | 0.6 | GO:0055119 | relaxation of cardiac muscle(GO:0055119) |
0.3 | 1.0 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.3 | 0.6 | GO:0042255 | ribosome assembly(GO:0042255) |
0.3 | 0.3 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.3 | 1.5 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.3 | 0.3 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.3 | 0.9 | GO:2000378 | negative regulation of reactive oxygen species metabolic process(GO:2000378) |
0.3 | 0.9 | GO:2000209 | regulation of anoikis(GO:2000209) |
0.3 | 0.3 | GO:0061009 | common bile duct development(GO:0061009) |
0.3 | 2.4 | GO:0019079 | viral genome replication(GO:0019079) |
0.3 | 1.2 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.3 | 0.3 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.3 | 0.6 | GO:0048162 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.3 | 1.8 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.3 | 1.8 | GO:0006352 | DNA-templated transcription, initiation(GO:0006352) |
0.3 | 1.8 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.3 | 1.2 | GO:0042990 | regulation of transcription factor import into nucleus(GO:0042990) |
0.3 | 0.9 | GO:0046782 | regulation of viral transcription(GO:0046782) |
0.3 | 14.2 | GO:0032259 | methylation(GO:0032259) |
0.3 | 1.2 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.3 | 0.3 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
0.3 | 2.3 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
0.3 | 0.3 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.3 | 1.4 | GO:0070269 | pyroptosis(GO:0070269) |
0.3 | 0.3 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.3 | 1.4 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.3 | 0.3 | GO:0033762 | response to glucagon(GO:0033762) |
0.3 | 3.1 | GO:0034308 | primary alcohol metabolic process(GO:0034308) |
0.3 | 0.8 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
0.3 | 0.6 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.3 | 1.4 | GO:0046677 | response to antibiotic(GO:0046677) |
0.3 | 0.3 | GO:0071107 | response to parathyroid hormone(GO:0071107) |
0.3 | 0.3 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.3 | 0.5 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.3 | 0.3 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.3 | 1.6 | GO:0006743 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.3 | 2.3 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.3 | 0.3 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.3 | 3.3 | GO:0008637 | apoptotic mitochondrial changes(GO:0008637) |
0.3 | 2.3 | GO:0071875 | adrenergic receptor signaling pathway(GO:0071875) |
0.3 | 3.1 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.3 | 0.8 | GO:0009629 | response to gravity(GO:0009629) |
0.2 | 2.2 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.2 | 1.0 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.2 | 0.2 | GO:0043276 | anoikis(GO:0043276) |
0.2 | 39.9 | GO:0043043 | peptide biosynthetic process(GO:0043043) |
0.2 | 0.2 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.2 | 0.7 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.2 | 1.0 | GO:0034976 | response to endoplasmic reticulum stress(GO:0034976) |
0.2 | 1.2 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.2 | 0.9 | GO:0006968 | cellular defense response(GO:0006968) |
0.2 | 0.2 | GO:0033034 | positive regulation of myeloid cell apoptotic process(GO:0033034) |
0.2 | 1.6 | GO:0030888 | regulation of B cell proliferation(GO:0030888) |
0.2 | 0.2 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.2 | 0.7 | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin(GO:0003081) |
0.2 | 0.7 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.2 | 0.4 | GO:0016445 | somatic diversification of immunoglobulins(GO:0016445) |
0.2 | 0.4 | GO:0042508 | tyrosine phosphorylation of Stat1 protein(GO:0042508) |
0.2 | 14.2 | GO:0051603 | proteolysis involved in cellular protein catabolic process(GO:0051603) |
0.2 | 1.5 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.2 | 0.2 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.2 | 0.6 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.2 | 1.5 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.2 | 11.9 | GO:0006281 | DNA repair(GO:0006281) |
0.2 | 0.8 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.2 | 1.6 | GO:0043280 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043280) |
0.2 | 13.2 | GO:0071222 | cellular response to lipopolysaccharide(GO:0071222) |
0.2 | 0.4 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.2 | 0.4 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.2 | 0.2 | GO:2000514 | regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043370) regulation of CD4-positive, alpha-beta T cell activation(GO:2000514) |
0.2 | 0.6 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.2 | 0.2 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.2 | 0.8 | GO:0044144 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.2 | 1.5 | GO:0017144 | drug metabolic process(GO:0017144) |
0.2 | 0.4 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.2 | 0.2 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.2 | 0.4 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.2 | 0.2 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.2 | 0.2 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.2 | 0.2 | GO:0019692 | 2'-deoxyribonucleotide metabolic process(GO:0009394) deoxyribose phosphate metabolic process(GO:0019692) |
0.2 | 4.3 | GO:0016071 | mRNA metabolic process(GO:0016071) |
0.2 | 0.6 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.2 | 0.6 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.2 | 0.2 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.2 | 0.9 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.2 | 0.7 | GO:0006959 | humoral immune response(GO:0006959) |
0.2 | 3.1 | GO:0048240 | sperm capacitation(GO:0048240) |
0.2 | 0.2 | GO:0034390 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
0.2 | 0.4 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.2 | 0.5 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.2 | 1.2 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.2 | 0.2 | GO:0072126 | positive regulation of glomerular mesangial cell proliferation(GO:0072126) |
0.2 | 0.2 | GO:0009124 | nucleoside monophosphate biosynthetic process(GO:0009124) |
0.2 | 0.7 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.2 | 0.7 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.2 | 0.2 | GO:0000956 | nuclear-transcribed mRNA catabolic process(GO:0000956) |
0.2 | 0.2 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.2 | 0.3 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.2 | 0.5 | GO:0007127 | meiosis I(GO:0007127) |
0.2 | 1.6 | GO:0031123 | RNA 3'-end processing(GO:0031123) |
0.2 | 1.0 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.2 | 0.2 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.2 | 1.9 | GO:0070527 | platelet aggregation(GO:0070527) |
0.2 | 1.5 | GO:0048286 | lung alveolus development(GO:0048286) |
0.2 | 0.2 | GO:0045023 | G0 to G1 transition(GO:0045023) regulation of G0 to G1 transition(GO:0070316) |
0.2 | 0.2 | GO:0042506 | tyrosine phosphorylation of Stat5 protein(GO:0042506) |
0.1 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.9 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 1.2 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.1 | 0.1 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.1 | 0.1 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 0.3 | GO:0032715 | negative regulation of interleukin-6 production(GO:0032715) |
0.1 | 1.5 | GO:0070647 | protein modification by small protein conjugation or removal(GO:0070647) |
0.1 | 0.3 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.1 | 0.1 | GO:0009164 | nucleoside catabolic process(GO:0009164) |
0.1 | 0.1 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.1 | 1.0 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.1 | 0.6 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.1 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
0.1 | 0.7 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 0.7 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.1 | 0.1 | GO:0061365 | positive regulation of triglyceride lipase activity(GO:0061365) |
0.1 | 0.1 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.1 | 0.8 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 1.7 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 0.8 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.1 | 0.1 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.1 | 1.0 | GO:1900004 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.1 | 3.9 | GO:0006396 | RNA processing(GO:0006396) |
0.1 | 0.1 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.1 | 0.4 | GO:0030033 | microvillus assembly(GO:0030033) |
0.1 | 0.1 | GO:0007567 | parturition(GO:0007567) |
0.1 | 0.4 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.1 | 0.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.2 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.1 | 0.2 | GO:0032620 | interleukin-17 production(GO:0032620) |
0.1 | 0.1 | GO:0060295 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.1 | 0.1 | GO:0032370 | positive regulation of lipid transport(GO:0032370) |
0.1 | 0.4 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.1 | 0.2 | GO:0042534 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
0.1 | 0.1 | GO:0002825 | regulation of T-helper 1 type immune response(GO:0002825) |
0.1 | 0.2 | GO:0006475 | internal protein amino acid acetylation(GO:0006475) |
0.1 | 0.2 | GO:0097531 | mast cell migration(GO:0097531) |
0.1 | 0.9 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.1 | 1.3 | GO:0072348 | sulfur compound transport(GO:0072348) |
0.1 | 0.1 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.1 | 15.1 | GO:0007283 | spermatogenesis(GO:0007283) |
0.1 | 0.2 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.1 | 0.1 | GO:1901201 | regulation of extracellular matrix assembly(GO:1901201) |
0.1 | 0.1 | GO:0002763 | positive regulation of myeloid leukocyte differentiation(GO:0002763) |
0.1 | 0.1 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.1 | 0.1 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.1 | 0.3 | GO:0048541 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.1 | 0.1 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.1 | 0.1 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.1 | 0.1 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.1 | 0.1 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.1 | 2.0 | GO:0006956 | complement activation(GO:0006956) |
0.1 | 0.1 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.1 | 0.5 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.1 | 0.1 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.1 | 0.1 | GO:0002155 | regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.1 | 0.1 | GO:0051132 | NK T cell activation(GO:0051132) |
0.1 | 1.3 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
0.1 | 0.2 | GO:0000959 | mitochondrial RNA metabolic process(GO:0000959) |
0.1 | 2.4 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.1 | 0.1 | GO:0045297 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.1 | 0.2 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.1 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.1 | 0.2 | GO:0015931 | nucleobase-containing compound transport(GO:0015931) |
0.1 | 0.1 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.1 | 0.1 | GO:0002583 | regulation of antigen processing and presentation of peptide antigen(GO:0002583) |
0.1 | 0.2 | GO:0002920 | regulation of humoral immune response(GO:0002920) |
0.0 | 0.1 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.0 | 0.0 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.0 | 2.7 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
0.0 | 0.2 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.0 | 0.0 | GO:0001562 | response to protozoan(GO:0001562) |
0.0 | 0.1 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.0 | 0.0 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.0 | 0.1 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.0 | 0.1 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.0 | 0.0 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.0 | 0.0 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.0 | 0.1 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.0 | 0.1 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.0 | 0.1 | GO:0042100 | B cell proliferation(GO:0042100) |
0.0 | 0.1 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.0 | 0.0 | GO:0032094 | response to food(GO:0032094) |
0.0 | 0.0 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.0 | 1.3 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.0 | 0.0 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.1 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.0 | 0.0 | GO:1900225 | regulation of NLRP3 inflammasome complex assembly(GO:1900225) |
0.0 | 0.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.0 | GO:0006473 | protein acetylation(GO:0006473) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.8 | 39.3 | GO:0072487 | MSL complex(GO:0072487) |
9.8 | 29.4 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
8.9 | 26.6 | GO:0005667 | transcription factor complex(GO:0005667) |
7.6 | 37.8 | GO:0016461 | unconventional myosin complex(GO:0016461) |
7.3 | 58.5 | GO:0001650 | fibrillar center(GO:0001650) |
7.2 | 21.5 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
6.9 | 27.6 | GO:0097524 | sperm plasma membrane(GO:0097524) |
6.8 | 27.3 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
6.5 | 26.1 | GO:0005642 | annulate lamellae(GO:0005642) |
6.5 | 45.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
6.3 | 19.0 | GO:0031094 | platelet dense tubular network(GO:0031094) |
6.3 | 25.1 | GO:0071141 | SMAD protein complex(GO:0071141) |
6.0 | 18.1 | GO:0043293 | apoptosome(GO:0043293) |
6.0 | 18.0 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
5.8 | 29.2 | GO:0005638 | lamin filament(GO:0005638) |
5.6 | 22.3 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
5.5 | 32.8 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
5.4 | 21.7 | GO:0005955 | calcineurin complex(GO:0005955) |
5.3 | 10.6 | GO:0097451 | glial limiting end-foot(GO:0097451) |
5.3 | 15.8 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
5.2 | 5.2 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
5.2 | 51.8 | GO:0031010 | ISWI-type complex(GO:0031010) |
5.2 | 61.9 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
5.1 | 20.6 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
5.1 | 61.3 | GO:0071564 | npBAF complex(GO:0071564) |
5.0 | 30.2 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
5.0 | 34.9 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
5.0 | 15.0 | GO:0097443 | sorting endosome(GO:0097443) |
5.0 | 14.9 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
4.9 | 19.5 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
4.8 | 14.4 | GO:0000811 | GINS complex(GO:0000811) |
4.7 | 19.0 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
4.7 | 23.3 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
4.6 | 18.5 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
4.6 | 150.4 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
4.4 | 44.2 | GO:0016580 | Sin3 complex(GO:0016580) |
4.4 | 202.2 | GO:0000118 | histone deacetylase complex(GO:0000118) |
4.4 | 13.1 | GO:0031523 | Myb complex(GO:0031523) |
4.4 | 13.1 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
4.3 | 64.9 | GO:0000421 | autophagosome membrane(GO:0000421) |
4.3 | 38.7 | GO:0000124 | SAGA complex(GO:0000124) |
4.3 | 12.9 | GO:1990462 | omegasome(GO:1990462) |
4.3 | 17.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
4.2 | 12.7 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
4.2 | 16.8 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
4.2 | 25.2 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
4.2 | 20.9 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
4.1 | 61.6 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
4.1 | 12.3 | GO:0005745 | m-AAA complex(GO:0005745) |
4.1 | 12.2 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
4.1 | 40.5 | GO:0090544 | BAF-type complex(GO:0090544) |
3.9 | 11.7 | GO:0031417 | NatC complex(GO:0031417) |
3.9 | 101.6 | GO:0031519 | PcG protein complex(GO:0031519) |
3.9 | 15.4 | GO:0044326 | dendritic spine neck(GO:0044326) |
3.9 | 27.0 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
3.8 | 15.3 | GO:0097431 | mitotic spindle pole(GO:0097431) |
3.8 | 45.6 | GO:0030914 | STAGA complex(GO:0030914) |
3.7 | 11.2 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
3.6 | 54.2 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
3.5 | 3.5 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
3.5 | 6.9 | GO:0070688 | MLL5-L complex(GO:0070688) |
3.5 | 72.5 | GO:0035145 | exon-exon junction complex(GO:0035145) |
3.4 | 37.7 | GO:0032039 | integrator complex(GO:0032039) |
3.4 | 33.6 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
3.4 | 3.4 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
3.3 | 16.7 | GO:0000235 | astral microtubule(GO:0000235) |
3.3 | 10.0 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
3.3 | 39.8 | GO:0010369 | chromocenter(GO:0010369) |
3.3 | 13.3 | GO:0000805 | X chromosome(GO:0000805) |
3.3 | 9.9 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
3.3 | 13.2 | GO:0030127 | COPII vesicle coat(GO:0030127) |
3.3 | 9.9 | GO:0031084 | BLOC-2 complex(GO:0031084) |
3.2 | 16.1 | GO:0033093 | Weibel-Palade body(GO:0033093) |
3.2 | 152.7 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
3.1 | 25.2 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
3.1 | 15.7 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
3.1 | 6.2 | GO:0033269 | internode region of axon(GO:0033269) |
3.1 | 6.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
3.0 | 33.4 | GO:0070938 | contractile ring(GO:0070938) |
3.0 | 15.1 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
3.0 | 21.0 | GO:0031931 | TORC1 complex(GO:0031931) |
3.0 | 8.9 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
2.9 | 11.8 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
2.9 | 11.7 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
2.9 | 26.1 | GO:0051286 | cell tip(GO:0051286) |
2.9 | 8.6 | GO:0071817 | MMXD complex(GO:0071817) |
2.9 | 14.3 | GO:0090543 | Flemming body(GO:0090543) |
2.8 | 25.6 | GO:0034709 | methylosome(GO:0034709) |
2.8 | 8.5 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
2.8 | 47.8 | GO:0005719 | nuclear euchromatin(GO:0005719) |
2.8 | 11.3 | GO:0036449 | microtubule minus-end(GO:0036449) |
2.8 | 25.1 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
2.8 | 19.4 | GO:0001939 | female pronucleus(GO:0001939) |
2.8 | 8.3 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
2.8 | 80.1 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
2.7 | 8.1 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
2.7 | 8.0 | GO:0055087 | Ski complex(GO:0055087) |
2.6 | 13.2 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
2.6 | 23.6 | GO:0031011 | Ino80 complex(GO:0031011) |
2.6 | 26.2 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
2.6 | 5.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
2.6 | 20.6 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
2.5 | 17.8 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
2.5 | 17.6 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
2.5 | 7.5 | GO:0097452 | GAIT complex(GO:0097452) |
2.5 | 12.4 | GO:0033503 | HULC complex(GO:0033503) |
2.5 | 19.8 | GO:1990909 | Wnt signalosome(GO:1990909) |
2.5 | 9.9 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
2.5 | 7.4 | GO:0042405 | nuclear inclusion body(GO:0042405) |
2.5 | 12.3 | GO:0045120 | pronucleus(GO:0045120) |
2.5 | 9.8 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
2.4 | 7.3 | GO:0097413 | Lewy body(GO:0097413) |
2.4 | 2.4 | GO:0005687 | U4 snRNP(GO:0005687) |
2.4 | 9.5 | GO:0035363 | histone locus body(GO:0035363) |
2.4 | 19.1 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
2.4 | 23.8 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
2.4 | 11.9 | GO:0044294 | dendritic growth cone(GO:0044294) |
2.4 | 11.8 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
2.3 | 145.5 | GO:0016363 | nuclear matrix(GO:0016363) |
2.3 | 37.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
2.3 | 7.0 | GO:0097149 | centralspindlin complex(GO:0097149) |
2.3 | 34.9 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
2.3 | 127.3 | GO:0016605 | PML body(GO:0016605) |
2.3 | 43.6 | GO:0000786 | nucleosome(GO:0000786) |
2.3 | 9.2 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
2.3 | 2.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
2.3 | 11.3 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
2.3 | 15.8 | GO:0061700 | GATOR2 complex(GO:0061700) |
2.2 | 6.7 | GO:0071797 | LUBAC complex(GO:0071797) |
2.2 | 20.2 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
2.2 | 46.8 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
2.2 | 261.7 | GO:0000790 | nuclear chromatin(GO:0000790) |
2.2 | 8.7 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
2.2 | 13.1 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
2.2 | 6.5 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
2.2 | 10.9 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
2.2 | 23.9 | GO:0031616 | spindle pole centrosome(GO:0031616) |
2.2 | 28.2 | GO:0031528 | microvillus membrane(GO:0031528) |
2.2 | 6.5 | GO:0000322 | storage vacuole(GO:0000322) |
2.2 | 17.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
2.2 | 47.5 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
2.1 | 10.7 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
2.1 | 21.5 | GO:0070852 | cell body fiber(GO:0070852) |
2.1 | 12.8 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
2.1 | 21.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
2.1 | 10.6 | GO:0061617 | MICOS complex(GO:0061617) |
2.1 | 8.4 | GO:0000796 | condensin complex(GO:0000796) |
2.1 | 2.1 | GO:0097427 | microtubule bundle(GO:0097427) |
2.1 | 12.6 | GO:0044327 | dendritic spine head(GO:0044327) |
2.1 | 18.8 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
2.1 | 16.6 | GO:0070652 | HAUS complex(GO:0070652) |
2.1 | 22.8 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
2.1 | 64.0 | GO:0016592 | mediator complex(GO:0016592) |
2.0 | 4.1 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
2.0 | 202.1 | GO:0072562 | blood microparticle(GO:0072562) |
2.0 | 63.2 | GO:0005876 | spindle microtubule(GO:0005876) |
2.0 | 109.3 | GO:0000785 | chromatin(GO:0000785) |
2.0 | 64.8 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
2.0 | 22.2 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
2.0 | 6.0 | GO:0089701 | U2AF(GO:0089701) |
2.0 | 6.0 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
2.0 | 52.2 | GO:0008180 | COP9 signalosome(GO:0008180) |
2.0 | 28.1 | GO:0001891 | phagocytic cup(GO:0001891) |
2.0 | 2.0 | GO:0016939 | kinesin II complex(GO:0016939) |
2.0 | 27.9 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
2.0 | 35.8 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
2.0 | 9.9 | GO:0097422 | tubular endosome(GO:0097422) |
2.0 | 6.0 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
2.0 | 7.9 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
2.0 | 5.9 | GO:1990130 | Iml1 complex(GO:1990130) |
2.0 | 2.0 | GO:0072686 | mitotic spindle(GO:0072686) |
2.0 | 3.9 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
2.0 | 3.9 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
2.0 | 23.6 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
2.0 | 21.6 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
2.0 | 11.7 | GO:0031415 | NatA complex(GO:0031415) |
1.9 | 5.8 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
1.9 | 1.9 | GO:0000439 | core TFIIH complex(GO:0000439) |
1.9 | 7.7 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
1.9 | 3.8 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
1.9 | 7.6 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
1.9 | 1.9 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
1.9 | 20.7 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
1.9 | 5.6 | GO:0005652 | nuclear lamina(GO:0005652) |
1.9 | 11.2 | GO:0097542 | ciliary tip(GO:0097542) |
1.9 | 9.3 | GO:0042575 | DNA polymerase complex(GO:0042575) |
1.9 | 1.9 | GO:0000346 | transcription export complex(GO:0000346) |
1.9 | 5.6 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
1.9 | 20.4 | GO:0017119 | Golgi transport complex(GO:0017119) |
1.8 | 27.4 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
1.8 | 5.5 | GO:0031932 | TORC2 complex(GO:0031932) |
1.8 | 5.4 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
1.8 | 7.1 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
1.8 | 23.1 | GO:0000242 | pericentriolar material(GO:0000242) |
1.8 | 16.0 | GO:0030894 | replisome(GO:0030894) |
1.8 | 19.4 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
1.7 | 7.0 | GO:0046581 | intercellular canaliculus(GO:0046581) |
1.7 | 8.7 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
1.7 | 10.4 | GO:0042587 | glycogen granule(GO:0042587) |
1.7 | 7.0 | GO:0071203 | WASH complex(GO:0071203) |
1.7 | 27.8 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
1.7 | 59.0 | GO:0045171 | intercellular bridge(GO:0045171) |
1.7 | 3.5 | GO:0000814 | ESCRT II complex(GO:0000814) |
1.7 | 3.5 | GO:0005879 | axonemal microtubule(GO:0005879) |
1.7 | 3.5 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
1.7 | 5.2 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
1.7 | 3.5 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
1.7 | 5.1 | GO:0031262 | Ndc80 complex(GO:0031262) |
1.7 | 187.2 | GO:0016604 | nuclear body(GO:0016604) |
1.7 | 10.2 | GO:0031209 | SCAR complex(GO:0031209) |
1.7 | 5.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
1.7 | 54.0 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
1.7 | 6.7 | GO:1990246 | uniplex complex(GO:1990246) |
1.7 | 58.8 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
1.7 | 3.4 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
1.7 | 36.6 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
1.7 | 15.0 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
1.7 | 6.6 | GO:0043596 | nuclear replication fork(GO:0043596) |
1.6 | 11.5 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
1.6 | 24.7 | GO:0042599 | lamellar body(GO:0042599) |
1.6 | 80.7 | GO:0005811 | lipid particle(GO:0005811) |
1.6 | 8.2 | GO:0005796 | Golgi lumen(GO:0005796) |
1.6 | 9.8 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
1.6 | 18.0 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
1.6 | 3.2 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
1.6 | 9.7 | GO:0034464 | BBSome(GO:0034464) |
1.6 | 12.9 | GO:0097539 | ciliary transition fiber(GO:0097539) |
1.6 | 3.2 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
1.6 | 4.8 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
1.6 | 4.7 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
1.6 | 12.6 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
1.6 | 1741.7 | GO:0005654 | nucleoplasm(GO:0005654) |
1.6 | 6.3 | GO:0000938 | GARP complex(GO:0000938) |
1.6 | 1.6 | GO:1990423 | RZZ complex(GO:1990423) |
1.6 | 9.4 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
1.6 | 4.7 | GO:0042612 | MHC class I protein complex(GO:0042612) |
1.6 | 7.8 | GO:0005682 | U5 snRNP(GO:0005682) |
1.6 | 17.1 | GO:0005916 | fascia adherens(GO:0005916) |
1.5 | 1.5 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
1.5 | 1.5 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
1.5 | 6.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
1.5 | 4.6 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
1.5 | 7.6 | GO:0005657 | replication fork(GO:0005657) |
1.5 | 12.2 | GO:0016600 | flotillin complex(GO:0016600) |
1.5 | 13.7 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
1.5 | 15.1 | GO:0030126 | COPI vesicle coat(GO:0030126) |
1.5 | 10.5 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
1.5 | 25.6 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
1.5 | 4.5 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
1.5 | 3.0 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
1.5 | 8.9 | GO:0044232 | organelle membrane contact site(GO:0044232) |
1.5 | 42.7 | GO:0005801 | cis-Golgi network(GO:0005801) |
1.5 | 4.4 | GO:0036157 | outer dynein arm(GO:0036157) |
1.5 | 49.5 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
1.4 | 5.8 | GO:0098645 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
1.4 | 5.7 | GO:0005795 | Golgi stack(GO:0005795) |
1.4 | 9.9 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
1.4 | 5.6 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
1.4 | 2.8 | GO:1990923 | PET complex(GO:1990923) |
1.4 | 2.8 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
1.4 | 2.8 | GO:0097470 | ribbon synapse(GO:0097470) |
1.4 | 8.1 | GO:0070820 | tertiary granule(GO:0070820) |
1.3 | 26.9 | GO:0005776 | autophagosome(GO:0005776) |
1.3 | 9.3 | GO:0033263 | CORVET complex(GO:0033263) |
1.3 | 9.3 | GO:0000815 | ESCRT III complex(GO:0000815) |
1.3 | 4.0 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
1.3 | 5.3 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
1.3 | 59.5 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
1.3 | 19.8 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
1.3 | 13.2 | GO:0097440 | apical dendrite(GO:0097440) |
1.3 | 31.6 | GO:0044438 | microbody part(GO:0044438) peroxisomal part(GO:0044439) |
1.3 | 6.5 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
1.3 | 5.2 | GO:0071010 | prespliceosome(GO:0071010) |
1.3 | 3.9 | GO:0098536 | deuterosome(GO:0098536) |
1.3 | 3.9 | GO:0097512 | cardiac myofibril(GO:0097512) |
1.3 | 35.9 | GO:0005905 | clathrin-coated pit(GO:0005905) |
1.3 | 5.0 | GO:0005869 | dynactin complex(GO:0005869) |
1.3 | 137.8 | GO:0031965 | nuclear membrane(GO:0031965) |
1.2 | 27.5 | GO:0035869 | ciliary transition zone(GO:0035869) |
1.2 | 3.7 | GO:0042583 | chromaffin granule(GO:0042583) |
1.2 | 11.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
1.2 | 3.7 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
1.2 | 2.5 | GO:0071437 | invadopodium(GO:0071437) |
1.2 | 2.4 | GO:0045180 | basal cortex(GO:0045180) |
1.2 | 36.6 | GO:0000502 | proteasome complex(GO:0000502) |
1.2 | 7.3 | GO:0071986 | Ragulator complex(GO:0071986) |
1.2 | 43.4 | GO:0030496 | midbody(GO:0030496) |
1.2 | 1.2 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
1.2 | 8.4 | GO:0031512 | motile primary cilium(GO:0031512) |
1.2 | 19.1 | GO:0005643 | nuclear pore(GO:0005643) |
1.2 | 75.2 | GO:0005681 | spliceosomal complex(GO:0005681) |
1.2 | 5.9 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
1.2 | 11.8 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
1.2 | 3.6 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
1.2 | 3.5 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
1.2 | 1.2 | GO:0008091 | spectrin(GO:0008091) |
1.2 | 109.4 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
1.2 | 7.0 | GO:0000801 | central element(GO:0000801) |
1.2 | 1.2 | GO:0098573 | intrinsic component of mitochondrial membrane(GO:0098573) |
1.1 | 8.0 | GO:0030008 | TRAPP complex(GO:0030008) |
1.1 | 4.6 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
1.1 | 3.4 | GO:0044194 | cytolytic granule(GO:0044194) |
1.1 | 18.1 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
1.1 | 11.3 | GO:0002102 | podosome(GO:0002102) |
1.1 | 4.5 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
1.1 | 72.1 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
1.1 | 4.5 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
1.1 | 22.3 | GO:0005605 | basal lamina(GO:0005605) |
1.1 | 75.0 | GO:0005759 | mitochondrial matrix(GO:0005759) |
1.1 | 1.1 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
1.1 | 6.5 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
1.1 | 7.6 | GO:0097225 | sperm midpiece(GO:0097225) |
1.1 | 1.1 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
1.1 | 2.2 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
1.1 | 8.6 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
1.1 | 6.4 | GO:0032009 | early phagosome(GO:0032009) |
1.1 | 140.0 | GO:0005694 | chromosome(GO:0005694) |
1.0 | 13.6 | GO:0002080 | acrosomal membrane(GO:0002080) |
1.0 | 5.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
1.0 | 63.9 | GO:0019867 | outer membrane(GO:0019867) |
1.0 | 3.0 | GO:0030430 | host cell cytoplasm(GO:0030430) host intracellular part(GO:0033646) host cell cytoplasm part(GO:0033655) intracellular region of host(GO:0043656) |
1.0 | 2.0 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
1.0 | 3.0 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
1.0 | 3.0 | GO:0045179 | apical cortex(GO:0045179) |
1.0 | 8.9 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
1.0 | 5.8 | GO:0055029 | DNA-directed RNA polymerase complex(GO:0000428) nuclear DNA-directed RNA polymerase complex(GO:0055029) |
1.0 | 4.8 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
1.0 | 1.9 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
1.0 | 23.8 | GO:0005844 | polysome(GO:0005844) |
1.0 | 196.0 | GO:0005925 | focal adhesion(GO:0005925) |
0.9 | 46.4 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.9 | 193.7 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.9 | 5.7 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.9 | 48.0 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.9 | 5.6 | GO:0031430 | M band(GO:0031430) |
0.9 | 2.7 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.9 | 0.9 | GO:0030990 | intraciliary transport particle(GO:0030990) |
0.9 | 11.8 | GO:0014704 | intercalated disc(GO:0014704) |
0.9 | 15.4 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.9 | 0.9 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.9 | 1.8 | GO:0072687 | meiotic spindle(GO:0072687) |
0.9 | 2.7 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.9 | 0.9 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.9 | 4.4 | GO:0016272 | prefoldin complex(GO:0016272) |
0.9 | 8.8 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.9 | 248.8 | GO:0005730 | nucleolus(GO:0005730) |
0.9 | 2.6 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.9 | 7.8 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.9 | 3.5 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.9 | 15.5 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.9 | 558.2 | GO:0005739 | mitochondrion(GO:0005739) |
0.8 | 0.8 | GO:0097525 | spliceosomal snRNP complex(GO:0097525) |
0.8 | 2.5 | GO:1990391 | DNA repair complex(GO:1990391) |
0.8 | 3.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.8 | 2.5 | GO:0048179 | activin receptor complex(GO:0048179) |
0.8 | 3.2 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.8 | 1.6 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.8 | 32.5 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.8 | 150.5 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.8 | 11.7 | GO:0001772 | immunological synapse(GO:0001772) |
0.8 | 20.2 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.8 | 23.3 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.7 | 0.7 | GO:0031902 | late endosome membrane(GO:0031902) |
0.7 | 111.2 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.7 | 38.7 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.7 | 18.9 | GO:0055037 | recycling endosome(GO:0055037) |
0.7 | 5.7 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.7 | 1.4 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.7 | 3.5 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.7 | 426.3 | GO:0005829 | cytosol(GO:0005829) |
0.7 | 29.8 | GO:0005938 | cell cortex(GO:0005938) |
0.7 | 1.3 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.7 | 51.9 | GO:0005874 | microtubule(GO:0005874) |
0.6 | 14.2 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.6 | 0.6 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.6 | 1.2 | GO:0070695 | FHF complex(GO:0070695) |
0.6 | 1.2 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.6 | 1168.1 | GO:0005634 | nucleus(GO:0005634) |
0.6 | 4.0 | GO:0031672 | A band(GO:0031672) |
0.5 | 0.5 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.5 | 3.1 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.5 | 1.0 | GO:0044292 | dendrite terminus(GO:0044292) |
0.5 | 54.0 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.5 | 1.0 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.5 | 0.5 | GO:0005840 | ribosome(GO:0005840) |
0.5 | 0.9 | GO:0071439 | clathrin complex(GO:0071439) |
0.5 | 2.7 | GO:0008305 | integrin complex(GO:0008305) |
0.4 | 0.4 | GO:0016528 | sarcoplasm(GO:0016528) |
0.4 | 0.4 | GO:0097255 | R2TP complex(GO:0097255) |
0.4 | 0.8 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.4 | 8.6 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.4 | 1.9 | GO:0016234 | inclusion body(GO:0016234) |
0.4 | 0.4 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.4 | 1.1 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.4 | 3.5 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.3 | 0.7 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.3 | 2.7 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.3 | 0.3 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.3 | 4.7 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.3 | 0.6 | GO:0097546 | ciliary base(GO:0097546) |
0.3 | 1.8 | GO:0032426 | stereocilium tip(GO:0032426) |
0.3 | 0.3 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.3 | 0.3 | GO:0042581 | specific granule(GO:0042581) |
0.3 | 13.2 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.3 | 1.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.3 | 0.8 | GO:0043203 | axon hillock(GO:0043203) |
0.3 | 0.5 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.3 | 1.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.2 | 0.2 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.2 | 0.4 | GO:0001520 | outer dense fiber(GO:0001520) |
0.2 | 0.2 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.2 | 0.2 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.2 | 0.4 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.2 | 0.7 | GO:0030904 | retromer complex(GO:0030904) |
0.2 | 0.9 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.2 | 75.4 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.2 | 0.3 | GO:0000922 | spindle pole(GO:0000922) |
0.2 | 2.3 | GO:0016459 | myosin complex(GO:0016459) |
0.2 | 136.4 | GO:0070062 | extracellular exosome(GO:0070062) |
0.1 | 0.9 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 0.6 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 0.1 | GO:0045178 | basal part of cell(GO:0045178) |
0.1 | 0.1 | GO:0030055 | cell-substrate junction(GO:0030055) |
0.1 | 0.1 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 0.1 | GO:0019814 | immunoglobulin complex(GO:0019814) B cell receptor complex(GO:0019815) |
0.1 | 6.7 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.8 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 2.2 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.1 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.0 | 4.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.0 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 0.0 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.5 | 10.5 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
9.5 | 38.0 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
8.8 | 26.4 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
8.8 | 70.1 | GO:0001163 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
8.6 | 25.7 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
8.5 | 34.2 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
8.5 | 33.9 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
8.2 | 32.8 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
8.2 | 8.2 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
7.9 | 23.8 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
7.8 | 23.5 | GO:0050692 | DBD domain binding(GO:0050692) |
7.7 | 23.2 | GO:1990188 | euchromatin binding(GO:1990188) |
7.5 | 52.6 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
7.4 | 22.2 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
7.3 | 14.6 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
7.1 | 21.4 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
6.9 | 27.6 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
6.6 | 19.9 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
6.6 | 19.9 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
6.2 | 24.9 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
6.2 | 24.6 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
6.1 | 18.4 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
6.1 | 36.7 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
6.1 | 18.2 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
6.0 | 17.9 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
5.9 | 17.8 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
5.9 | 17.6 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
5.8 | 109.9 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
5.7 | 17.1 | GO:0019961 | interferon binding(GO:0019961) |
5.7 | 17.1 | GO:0050816 | phosphothreonine binding(GO:0050816) |
5.6 | 28.0 | GO:1990239 | steroid hormone binding(GO:1990239) |
5.6 | 22.2 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
5.5 | 21.8 | GO:0009374 | biotin binding(GO:0009374) |
5.4 | 32.7 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
5.4 | 16.3 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
5.2 | 15.5 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
5.0 | 15.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
5.0 | 25.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
5.0 | 15.0 | GO:0070644 | vitamin D response element binding(GO:0070644) |
5.0 | 44.6 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
4.8 | 14.4 | GO:0055100 | adiponectin binding(GO:0055100) |
4.8 | 14.4 | GO:1990715 | mRNA CDS binding(GO:1990715) |
4.8 | 19.2 | GO:0004046 | aminoacylase activity(GO:0004046) |
4.8 | 62.2 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
4.8 | 23.9 | GO:0070061 | fructose binding(GO:0070061) |
4.8 | 43.0 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
4.8 | 19.1 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
4.7 | 19.0 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
4.7 | 14.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
4.7 | 14.1 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
4.7 | 18.6 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
4.6 | 13.9 | GO:0004359 | glutaminase activity(GO:0004359) |
4.6 | 4.6 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
4.6 | 13.7 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
4.5 | 13.4 | GO:0030350 | iron-responsive element binding(GO:0030350) |
4.4 | 8.8 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
4.4 | 21.9 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
4.4 | 52.4 | GO:0017166 | vinculin binding(GO:0017166) |
4.4 | 17.4 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
4.3 | 26.0 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
4.3 | 25.8 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
4.3 | 29.8 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
4.3 | 21.3 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
4.3 | 12.8 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
4.2 | 126.6 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
4.2 | 16.8 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
4.2 | 24.9 | GO:0034046 | poly(G) binding(GO:0034046) |
4.1 | 20.7 | GO:0030274 | LIM domain binding(GO:0030274) |
4.1 | 16.5 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
4.0 | 4.0 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
4.0 | 8.0 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
4.0 | 95.4 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
4.0 | 15.8 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
4.0 | 15.8 | GO:0070878 | primary miRNA binding(GO:0070878) |
3.9 | 51.2 | GO:0008432 | JUN kinase binding(GO:0008432) |
3.9 | 7.7 | GO:0050693 | LBD domain binding(GO:0050693) |
3.9 | 19.3 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
3.9 | 3.9 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
3.9 | 73.2 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
3.9 | 30.8 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
3.9 | 119.4 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
3.9 | 34.7 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
3.8 | 19.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
3.8 | 11.5 | GO:0030519 | snoRNP binding(GO:0030519) |
3.8 | 23.0 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
3.8 | 87.8 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
3.8 | 19.0 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
3.8 | 11.3 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
3.7 | 15.0 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
3.7 | 22.1 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
3.7 | 11.0 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
3.7 | 22.0 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
3.6 | 39.8 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
3.6 | 10.8 | GO:0008142 | oxysterol binding(GO:0008142) |
3.6 | 92.9 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
3.6 | 14.3 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
3.6 | 7.1 | GO:0019237 | centromeric DNA binding(GO:0019237) |
3.5 | 7.0 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
3.5 | 10.5 | GO:0032142 | single guanine insertion binding(GO:0032142) |
3.5 | 7.0 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
3.5 | 31.1 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
3.4 | 17.1 | GO:0070728 | leucine binding(GO:0070728) |
3.4 | 34.2 | GO:0031996 | thioesterase binding(GO:0031996) |
3.4 | 13.4 | GO:0070410 | co-SMAD binding(GO:0070410) |
3.3 | 10.0 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
3.3 | 36.6 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
3.3 | 6.6 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
3.3 | 43.0 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
3.3 | 36.4 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
3.3 | 23.1 | GO:0035197 | siRNA binding(GO:0035197) |
3.3 | 9.9 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
3.3 | 16.5 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
3.3 | 13.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
3.3 | 3.3 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
3.3 | 9.8 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
3.3 | 19.6 | GO:0001727 | lipid kinase activity(GO:0001727) |
3.3 | 3.3 | GO:0016662 | oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) |
3.3 | 9.8 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
3.2 | 29.2 | GO:0019789 | SUMO transferase activity(GO:0019789) |
3.2 | 87.1 | GO:0042162 | telomeric DNA binding(GO:0042162) |
3.2 | 35.2 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
3.2 | 9.5 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
3.2 | 9.5 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
3.2 | 12.7 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
3.2 | 15.8 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
3.1 | 15.7 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
3.1 | 15.7 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
3.1 | 15.5 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
3.1 | 15.4 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
3.1 | 15.4 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
3.1 | 9.2 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
3.1 | 104.7 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
3.1 | 15.4 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
3.1 | 9.2 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
3.1 | 125.6 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
3.1 | 21.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
3.0 | 64.0 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
3.0 | 30.3 | GO:0032452 | histone demethylase activity(GO:0032452) |
3.0 | 9.0 | GO:0004064 | arylesterase activity(GO:0004064) |
3.0 | 35.8 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
3.0 | 5.9 | GO:0035173 | histone kinase activity(GO:0035173) |
2.9 | 44.2 | GO:0050681 | androgen receptor binding(GO:0050681) |
2.9 | 8.8 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
2.9 | 8.8 | GO:0030619 | U1 snRNA binding(GO:0030619) |
2.9 | 8.7 | GO:0050815 | phosphoserine binding(GO:0050815) |
2.9 | 26.1 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
2.9 | 14.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
2.9 | 5.8 | GO:0030911 | TPR domain binding(GO:0030911) |
2.9 | 68.8 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
2.9 | 51.4 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
2.9 | 14.3 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
2.8 | 42.7 | GO:0001221 | transcription cofactor binding(GO:0001221) |
2.8 | 42.6 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
2.8 | 11.3 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
2.8 | 28.2 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
2.8 | 2.8 | GO:0051434 | BH3 domain binding(GO:0051434) |
2.8 | 11.3 | GO:0061665 | SUMO ligase activity(GO:0061665) |
2.8 | 8.4 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
2.8 | 8.4 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
2.8 | 11.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
2.8 | 8.3 | GO:0036033 | mediator complex binding(GO:0036033) |
2.8 | 8.3 | GO:0031014 | troponin T binding(GO:0031014) |
2.8 | 16.5 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
2.7 | 11.0 | GO:0015232 | heme transporter activity(GO:0015232) |
2.7 | 8.2 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
2.7 | 21.9 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
2.7 | 5.4 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
2.7 | 10.9 | GO:0000182 | rDNA binding(GO:0000182) |
2.7 | 5.4 | GO:0005119 | smoothened binding(GO:0005119) |
2.7 | 10.8 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
2.7 | 2.7 | GO:0051525 | NFAT protein binding(GO:0051525) |
2.7 | 8.1 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
2.7 | 26.9 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
2.7 | 48.2 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
2.6 | 5.3 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
2.6 | 13.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
2.6 | 28.7 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
2.6 | 33.9 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
2.6 | 5.2 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
2.6 | 2.6 | GO:0003696 | satellite DNA binding(GO:0003696) |
2.6 | 7.8 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
2.6 | 15.5 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
2.6 | 10.3 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
2.6 | 18.0 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
2.6 | 5.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
2.6 | 12.8 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
2.5 | 5.1 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
2.5 | 48.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
2.5 | 10.2 | GO:0005534 | galactose binding(GO:0005534) |
2.5 | 15.2 | GO:0008199 | ferric iron binding(GO:0008199) |
2.5 | 15.2 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
2.5 | 17.7 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
2.5 | 27.7 | GO:0035497 | cAMP response element binding(GO:0035497) |
2.5 | 5.0 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
2.5 | 20.0 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
2.5 | 15.0 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
2.5 | 34.9 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
2.5 | 5.0 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
2.5 | 12.4 | GO:0032184 | SUMO polymer binding(GO:0032184) |
2.5 | 4.9 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
2.5 | 7.4 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
2.4 | 7.3 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
2.4 | 14.6 | GO:0050897 | cobalt ion binding(GO:0050897) |
2.4 | 7.3 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
2.4 | 9.7 | GO:0030984 | kininogen binding(GO:0030984) |
2.4 | 12.0 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
2.4 | 7.2 | GO:0035174 | histone serine kinase activity(GO:0035174) histone kinase activity (H3-S10 specific)(GO:0035175) |
2.4 | 7.2 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
2.4 | 9.5 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
2.4 | 66.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
2.4 | 19.0 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
2.4 | 23.7 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
2.4 | 7.1 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
2.4 | 11.8 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
2.4 | 18.9 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
2.3 | 7.0 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
2.3 | 4.7 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
2.3 | 11.7 | GO:0017040 | ceramidase activity(GO:0017040) |
2.3 | 4.7 | GO:0051425 | PTB domain binding(GO:0051425) |
2.3 | 51.3 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
2.3 | 9.3 | GO:0043559 | insulin binding(GO:0043559) |
2.3 | 32.4 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
2.3 | 6.9 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
2.3 | 11.5 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
2.3 | 11.4 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
2.3 | 6.8 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
2.3 | 2.3 | GO:0035877 | death effector domain binding(GO:0035877) |
2.3 | 6.8 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
2.3 | 9.1 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
2.3 | 11.3 | GO:0005346 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
2.3 | 2.3 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
2.3 | 22.5 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
2.3 | 27.0 | GO:0035326 | enhancer binding(GO:0035326) |
2.2 | 9.0 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
2.2 | 31.2 | GO:0070717 | poly-purine tract binding(GO:0070717) |
2.2 | 15.6 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
2.2 | 33.3 | GO:0043531 | ADP binding(GO:0043531) |
2.2 | 4.4 | GO:0004104 | cholinesterase activity(GO:0004104) |
2.2 | 6.7 | GO:0015205 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
2.2 | 20.0 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
2.2 | 8.8 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
2.2 | 22.0 | GO:0004407 | histone deacetylase activity(GO:0004407) |
2.2 | 6.6 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
2.2 | 13.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
2.2 | 17.4 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
2.2 | 4.3 | GO:0034452 | dynactin binding(GO:0034452) |
2.2 | 6.5 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
2.2 | 19.5 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
2.2 | 8.7 | GO:0045118 | L-histidine transmembrane transporter activity(GO:0005290) azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
2.2 | 19.5 | GO:0034576 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
2.1 | 6.4 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
2.1 | 23.6 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
2.1 | 6.4 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
2.1 | 38.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
2.1 | 32.1 | GO:0017049 | GTP-Rho binding(GO:0017049) |
2.1 | 6.4 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
2.1 | 10.7 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
2.1 | 4.3 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
2.1 | 12.7 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
2.1 | 21.2 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
2.1 | 4.2 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
2.1 | 12.7 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
2.1 | 14.8 | GO:0004385 | guanylate kinase activity(GO:0004385) |
2.1 | 6.3 | GO:0051380 | beta-adrenergic receptor activity(GO:0004939) norepinephrine binding(GO:0051380) |
2.1 | 6.3 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
2.1 | 16.7 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
2.1 | 6.3 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
2.1 | 6.3 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
2.1 | 27.0 | GO:0001618 | virus receptor activity(GO:0001618) |
2.1 | 4.1 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
2.1 | 8.3 | GO:0015057 | thrombin receptor activity(GO:0015057) |
2.1 | 6.2 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
2.1 | 4.1 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
2.1 | 6.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
2.1 | 6.2 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
2.1 | 10.3 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
2.1 | 32.9 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
2.0 | 8.2 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
2.0 | 66.8 | GO:0035064 | methylated histone binding(GO:0035064) |
2.0 | 10.1 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
2.0 | 227.4 | GO:0003714 | transcription corepressor activity(GO:0003714) |
2.0 | 4.0 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
2.0 | 2.0 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
2.0 | 13.8 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
2.0 | 77.0 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
2.0 | 7.9 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
2.0 | 17.7 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
2.0 | 2.0 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
2.0 | 82.1 | GO:0016836 | hydro-lyase activity(GO:0016836) |
1.9 | 1.9 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
1.9 | 3.9 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
1.9 | 3.9 | GO:0016803 | hydrolase activity, acting on ether bonds(GO:0016801) ether hydrolase activity(GO:0016803) |
1.9 | 25.3 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
1.9 | 7.8 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
1.9 | 21.3 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
1.9 | 7.7 | GO:0002060 | purine nucleobase binding(GO:0002060) |
1.9 | 3.8 | GO:0048185 | activin binding(GO:0048185) |
1.9 | 9.6 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
1.9 | 5.7 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
1.9 | 24.5 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
1.9 | 54.6 | GO:0031593 | polyubiquitin binding(GO:0031593) |
1.9 | 5.6 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
1.9 | 7.5 | GO:0032183 | SUMO binding(GO:0032183) |
1.9 | 3.7 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
1.9 | 14.9 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
1.9 | 37.2 | GO:0008483 | transaminase activity(GO:0008483) |
1.9 | 3.7 | GO:0031685 | adenosine receptor binding(GO:0031685) |
1.8 | 5.5 | GO:0019002 | GMP binding(GO:0019002) |
1.8 | 7.4 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
1.8 | 7.4 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
1.8 | 11.1 | GO:0050733 | RS domain binding(GO:0050733) |
1.8 | 12.9 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
1.8 | 16.5 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
1.8 | 27.4 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
1.8 | 1.8 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
1.8 | 5.5 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
1.8 | 5.5 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
1.8 | 7.2 | GO:0070513 | death domain binding(GO:0070513) |
1.8 | 25.3 | GO:0001671 | ATPase activator activity(GO:0001671) |
1.8 | 1.8 | GO:0004622 | lysophospholipase activity(GO:0004622) |
1.8 | 7.2 | GO:0005047 | signal recognition particle binding(GO:0005047) |
1.8 | 10.8 | GO:0031419 | cobalamin binding(GO:0031419) |
1.8 | 10.8 | GO:0030983 | mismatched DNA binding(GO:0030983) |
1.8 | 12.6 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
1.8 | 3.6 | GO:0043426 | MRF binding(GO:0043426) |
1.8 | 10.7 | GO:0015288 | porin activity(GO:0015288) |
1.8 | 8.9 | GO:0008430 | selenium binding(GO:0008430) |
1.8 | 5.3 | GO:0031491 | nucleosome binding(GO:0031491) |
1.8 | 7.1 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
1.8 | 3.5 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
1.8 | 10.6 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
1.8 | 5.3 | GO:0051734 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) ATP-dependent polynucleotide kinase activity(GO:0051734) |
1.8 | 7.1 | GO:0042015 | interleukin-20 binding(GO:0042015) |
1.8 | 5.3 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
1.7 | 22.7 | GO:0017091 | AU-rich element binding(GO:0017091) |
1.7 | 5.2 | GO:1901612 | cardiolipin binding(GO:1901612) |
1.7 | 29.6 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
1.7 | 15.7 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
1.7 | 5.2 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
1.7 | 6.9 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
1.7 | 5.2 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
1.7 | 5.2 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.7 | 3.4 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
1.7 | 3.4 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
1.7 | 22.2 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
1.7 | 285.8 | GO:0043773 | UDP-N-acetylmuramoylalanyl-D-glutamyl-2,6-diaminopimelate-D-alanyl-D-alanine ligase activity(GO:0008766) ribosomal S6-glutamic acid ligase activity(GO:0018169) coenzyme F420-0 gamma-glutamyl ligase activity(GO:0043773) coenzyme F420-2 alpha-glutamyl ligase activity(GO:0043774) protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) protein-glycine ligase activity, elongating(GO:0070737) tubulin-glycine ligase activity(GO:0070738) |
1.7 | 5.1 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
1.7 | 10.1 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
1.7 | 6.7 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
1.7 | 10.1 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
1.7 | 11.8 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
1.7 | 3.3 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
1.7 | 38.5 | GO:0008536 | Ran GTPase binding(GO:0008536) |
1.7 | 6.7 | GO:1990405 | protein antigen binding(GO:1990405) |
1.7 | 3.3 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
1.7 | 21.5 | GO:0017025 | TBP-class protein binding(GO:0017025) |
1.7 | 5.0 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
1.7 | 3.3 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
1.7 | 34.7 | GO:0070063 | RNA polymerase binding(GO:0070063) |
1.6 | 8.2 | GO:0035473 | lipase binding(GO:0035473) |
1.6 | 8.2 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
1.6 | 19.5 | GO:0003924 | GTPase activity(GO:0003924) |
1.6 | 22.6 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
1.6 | 8.1 | GO:0008494 | translation activator activity(GO:0008494) |
1.6 | 3.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
1.6 | 95.0 | GO:0031072 | heat shock protein binding(GO:0031072) |
1.6 | 86.9 | GO:0017048 | Rho GTPase binding(GO:0017048) |
1.6 | 17.7 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
1.6 | 8.0 | GO:0052723 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
1.6 | 4.7 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
1.6 | 6.3 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
1.6 | 6.3 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
1.6 | 4.7 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
1.6 | 15.7 | GO:0010181 | FMN binding(GO:0010181) |
1.6 | 20.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
1.6 | 9.4 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
1.6 | 6.2 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
1.6 | 7.8 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
1.6 | 6.2 | GO:0030515 | snoRNA binding(GO:0030515) |
1.6 | 15.5 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
1.5 | 3.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
1.5 | 12.4 | GO:0005521 | lamin binding(GO:0005521) |
1.5 | 15.4 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
1.5 | 7.7 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
1.5 | 6.1 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
1.5 | 3.1 | GO:0034618 | arginine binding(GO:0034618) |
1.5 | 35.2 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
1.5 | 4.6 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
1.5 | 10.7 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
1.5 | 3.0 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
1.5 | 4.5 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
1.5 | 18.0 | GO:0045502 | dynein binding(GO:0045502) |
1.5 | 24.0 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
1.5 | 7.5 | GO:0008097 | 5S rRNA binding(GO:0008097) |
1.5 | 19.3 | GO:0036002 | pre-mRNA binding(GO:0036002) |
1.5 | 5.9 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
1.5 | 30.9 | GO:0003684 | damaged DNA binding(GO:0003684) |
1.5 | 1.5 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
1.5 | 55.7 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
1.5 | 10.2 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
1.5 | 68.5 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
1.5 | 4.4 | GO:0031432 | titin binding(GO:0031432) |
1.5 | 14.6 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
1.5 | 21.8 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
1.4 | 8.7 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
1.4 | 4.3 | GO:0016018 | cyclosporin A binding(GO:0016018) |
1.4 | 2.9 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
1.4 | 133.1 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
1.4 | 1.4 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
1.4 | 5.7 | GO:0003688 | DNA replication origin binding(GO:0003688) |
1.4 | 1.4 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
1.4 | 2.9 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
1.4 | 19.9 | GO:0051059 | NF-kappaB binding(GO:0051059) |
1.4 | 8.5 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
1.4 | 70.9 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
1.4 | 2.8 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
1.4 | 1.4 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.4 | 4.2 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
1.4 | 7.0 | GO:0050700 | CARD domain binding(GO:0050700) |
1.4 | 46.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
1.4 | 8.4 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
1.4 | 7.0 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
1.4 | 4.2 | GO:1990460 | leptin receptor binding(GO:1990460) |
1.4 | 5.5 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
1.4 | 2.8 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
1.4 | 27.6 | GO:0043130 | ubiquitin binding(GO:0043130) |
1.4 | 4.1 | GO:0038100 | nodal binding(GO:0038100) |
1.4 | 8.3 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
1.4 | 128.0 | GO:0017137 | Rab GTPase binding(GO:0017137) |
1.4 | 2.7 | GO:0005113 | patched binding(GO:0005113) |
1.4 | 4.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
1.4 | 4.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
1.4 | 2.7 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
1.4 | 20.4 | GO:0001047 | core promoter binding(GO:0001047) |
1.4 | 6.8 | GO:0070064 | proline-rich region binding(GO:0070064) |
1.3 | 6.7 | GO:0005536 | glucose binding(GO:0005536) |
1.3 | 58.8 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
1.3 | 6.6 | GO:0004017 | adenylate kinase activity(GO:0004017) |
1.3 | 6.6 | GO:0003993 | acid phosphatase activity(GO:0003993) |
1.3 | 31.6 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
1.3 | 1.3 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
1.3 | 5.2 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
1.3 | 5.2 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
1.3 | 11.8 | GO:0034946 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
1.3 | 9.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
1.3 | 16.9 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
1.3 | 2.6 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
1.3 | 3.9 | GO:0071253 | connexin binding(GO:0071253) |
1.3 | 5.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
1.3 | 7.7 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
1.3 | 3.8 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
1.3 | 7.7 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
1.3 | 1.3 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
1.3 | 6.4 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
1.3 | 2.5 | GO:1990446 | snRNP binding(GO:0070990) U1 snRNP binding(GO:1990446) |
1.3 | 3.8 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
1.3 | 56.5 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
1.3 | 5.0 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
1.3 | 3.8 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
1.2 | 7.5 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
1.2 | 3.7 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
1.2 | 9.9 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
1.2 | 3.7 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
1.2 | 14.8 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
1.2 | 9.9 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
1.2 | 4.9 | GO:0030572 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
1.2 | 52.9 | GO:0019003 | GDP binding(GO:0019003) |
1.2 | 16.0 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
1.2 | 24.6 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
1.2 | 17.1 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
1.2 | 6.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
1.2 | 6.1 | GO:0019238 | GTP cyclohydrolase activity(GO:0003933) cyclohydrolase activity(GO:0019238) |
1.2 | 21.8 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
1.2 | 1.2 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
1.2 | 4.8 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
1.2 | 4.8 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
1.2 | 2.4 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
1.2 | 6.0 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
1.2 | 13.0 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
1.2 | 2.4 | GO:0035671 | enone reductase activity(GO:0035671) |
1.2 | 3.5 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
1.2 | 50.8 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
1.2 | 4.7 | GO:0019808 | polyamine binding(GO:0019808) |
1.2 | 2.4 | GO:0016893 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters(GO:0016893) |
1.2 | 3.5 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
1.2 | 2.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
1.2 | 3.5 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
1.2 | 3.5 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
1.1 | 1.1 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
1.1 | 1.1 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
1.1 | 2.3 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
1.1 | 3.4 | GO:0070034 | telomerase RNA binding(GO:0070034) |
1.1 | 52.3 | GO:0008565 | protein transporter activity(GO:0008565) |
1.1 | 6.8 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
1.1 | 26.0 | GO:0042826 | histone deacetylase binding(GO:0042826) |
1.1 | 7.9 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
1.1 | 2.2 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
1.1 | 16.8 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
1.1 | 22.4 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
1.1 | 27.9 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
1.1 | 14.5 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
1.1 | 14.5 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
1.1 | 8.9 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
1.1 | 1.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
1.1 | 6.7 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
1.1 | 2.2 | GO:0019770 | IgG receptor activity(GO:0019770) |
1.1 | 16.6 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
1.1 | 5.5 | GO:0070402 | NADPH binding(GO:0070402) |
1.1 | 19.8 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
1.1 | 772.1 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
1.1 | 7.6 | GO:0030145 | manganese ion binding(GO:0030145) |
1.1 | 14.0 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
1.1 | 4.3 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
1.1 | 78.1 | GO:0000287 | magnesium ion binding(GO:0000287) |
1.1 | 28.9 | GO:0051087 | chaperone binding(GO:0051087) |
1.1 | 8.5 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
1.1 | 8.5 | GO:0005123 | death receptor binding(GO:0005123) |
1.1 | 12.7 | GO:0034792 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
1.1 | 1.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
1.1 | 5.3 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
1.1 | 7.4 | GO:0008327 | methyl-CpG binding(GO:0008327) |
1.1 | 4.2 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
1.0 | 2.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
1.0 | 21.8 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
1.0 | 1.0 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
1.0 | 1.0 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
1.0 | 6.1 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
1.0 | 3.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
1.0 | 12.2 | GO:0008198 | ferrous iron binding(GO:0008198) |
1.0 | 122.7 | GO:0003682 | chromatin binding(GO:0003682) |
1.0 | 2.0 | GO:0031369 | translation initiation factor binding(GO:0031369) |
1.0 | 3.0 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
1.0 | 4.0 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
1.0 | 6.0 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
1.0 | 5.0 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
1.0 | 2.0 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
1.0 | 2.0 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
1.0 | 9.0 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
1.0 | 2.0 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
1.0 | 7.0 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
1.0 | 5.0 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
1.0 | 2.0 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
1.0 | 3.0 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
1.0 | 19.8 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
1.0 | 41.6 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
1.0 | 10.9 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
1.0 | 6.9 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
1.0 | 2.9 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
1.0 | 6.8 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
1.0 | 8.8 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
1.0 | 2.9 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
1.0 | 2.9 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
1.0 | 3.9 | GO:0043422 | protein kinase B binding(GO:0043422) |
1.0 | 3.9 | GO:0070628 | proteasome binding(GO:0070628) |
1.0 | 2.9 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
1.0 | 88.5 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
1.0 | 1.9 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.9 | 6.6 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.9 | 10.4 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.9 | 1.9 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.9 | 6.6 | GO:0034817 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.9 | 0.9 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.9 | 5.5 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.9 | 22.5 | GO:0042393 | histone binding(GO:0042393) |
0.9 | 2.7 | GO:0052813 | phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.9 | 10.8 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.9 | 0.9 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.9 | 0.9 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.9 | 4.5 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.9 | 9.8 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.9 | 6.3 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.9 | 5.4 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.9 | 4.4 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.9 | 2.7 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.9 | 4.4 | GO:0034841 | succinate-CoA ligase activity(GO:0004774) 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.9 | 1.8 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.9 | 2.6 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.9 | 2.6 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.9 | 48.2 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.9 | 10.5 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.9 | 2.6 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.9 | 51.7 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.8 | 3.4 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.8 | 8.5 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.8 | 7.6 | GO:0004568 | chitinase activity(GO:0004568) |
0.8 | 4.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.8 | 1.7 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.8 | 22.8 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.8 | 6.7 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.8 | 7.6 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.8 | 26.0 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.8 | 11.7 | GO:0052890 | oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
0.8 | 2.5 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.8 | 1.7 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.8 | 11.6 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.8 | 1.7 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.8 | 3.3 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.8 | 7.4 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.8 | 4.9 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.8 | 0.8 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.8 | 8.2 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.8 | 13.9 | GO:0001848 | complement binding(GO:0001848) |
0.8 | 17.9 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.8 | 34.2 | GO:0004175 | endopeptidase activity(GO:0004175) |
0.8 | 2.4 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.8 | 16.2 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.8 | 51.0 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.8 | 0.8 | GO:0097617 | annealing helicase activity(GO:0036310) annealing activity(GO:0097617) |
0.8 | 12.0 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.8 | 17.6 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.8 | 11.2 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.8 | 0.8 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.8 | 7.2 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.8 | 19.0 | GO:0044823 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.8 | 3.9 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.8 | 14.7 | GO:0016875 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.8 | 8.5 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.8 | 5.4 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.8 | 4.6 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.8 | 3.8 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.7 | 68.2 | GO:0008134 | transcription factor binding(GO:0008134) |
0.7 | 1.5 | GO:2001070 | starch binding(GO:2001070) |
0.7 | 3.7 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.7 | 20.2 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.7 | 0.7 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.7 | 1.5 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.7 | 4.4 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.7 | 3.7 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.7 | 3.6 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.7 | 90.9 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.7 | 9.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.7 | 5.7 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.7 | 1.4 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.7 | 0.7 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.7 | 3.5 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.7 | 7.8 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.7 | 4.1 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.7 | 27.8 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.7 | 27.1 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.7 | 12.8 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
0.7 | 2.0 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.7 | 6.1 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.7 | 3.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.7 | 10.7 | GO:0005537 | mannose binding(GO:0005537) |
0.7 | 2.0 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.7 | 2.0 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.7 | 0.7 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.7 | 2.0 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.7 | 3.3 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.7 | 0.7 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.7 | 2.6 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.6 | 4.5 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.6 | 5.7 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.6 | 0.6 | GO:0030371 | translation repressor activity(GO:0030371) |
0.6 | 1.9 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.6 | 13.8 | GO:0050699 | WW domain binding(GO:0050699) |
0.6 | 114.3 | GO:0005525 | GTP binding(GO:0005525) |
0.6 | 3.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.6 | 1.2 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.6 | 3.1 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.6 | 1.8 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.6 | 2.4 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.6 | 1.2 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.6 | 10.8 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.6 | 3.0 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.6 | 9.4 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.6 | 1.8 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.6 | 3.5 | GO:0009055 | electron carrier activity(GO:0009055) |
0.6 | 3.4 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.6 | 1.7 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.6 | 1.1 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.6 | 0.6 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.6 | 1.1 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.6 | 0.6 | GO:0019843 | rRNA binding(GO:0019843) |
0.6 | 2.2 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.5 | 12.6 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.5 | 9.9 | GO:0030507 | spectrin binding(GO:0030507) |
0.5 | 1.6 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.5 | 11.4 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.5 | 1.6 | GO:0043515 | kinetochore binding(GO:0043515) |
0.5 | 22.1 | GO:0005319 | lipid transporter activity(GO:0005319) |
0.5 | 2.7 | GO:0002039 | p53 binding(GO:0002039) |
0.5 | 1.1 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.5 | 403.8 | GO:0003677 | DNA binding(GO:0003677) |
0.5 | 5.3 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.5 | 1.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.5 | 16.3 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.5 | 2.1 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.5 | 1.6 | GO:0070403 | NAD+ binding(GO:0070403) |
0.5 | 0.5 | GO:0004096 | catalase activity(GO:0004096) |
0.5 | 2.0 | GO:0016208 | AMP binding(GO:0016208) |
0.5 | 3.9 | GO:0000049 | tRNA binding(GO:0000049) |
0.5 | 8.4 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.5 | 1.0 | GO:0080014 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.5 | 1.0 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.5 | 1.0 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.5 | 3.4 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.5 | 1.0 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.5 | 3.3 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.5 | 2.4 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.5 | 0.5 | GO:0004518 | nuclease activity(GO:0004518) |
0.5 | 0.9 | GO:0019213 | deacetylase activity(GO:0019213) |
0.5 | 0.9 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.5 | 2.3 | GO:0050544 | icosanoid binding(GO:0050542) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
0.5 | 3.3 | GO:0039706 | co-receptor binding(GO:0039706) |
0.5 | 1.4 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.5 | 0.5 | GO:0051373 | FATZ binding(GO:0051373) |
0.5 | 1.8 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.4 | 1.3 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.4 | 3.1 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.4 | 2.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.4 | 3.1 | GO:0019209 | kinase activator activity(GO:0019209) |
0.4 | 5.7 | GO:0003785 | actin monomer binding(GO:0003785) |
0.4 | 42.4 | GO:0003779 | actin binding(GO:0003779) |
0.4 | 2.2 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.4 | 2.2 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.4 | 1.8 | GO:0004459 | lactate dehydrogenase activity(GO:0004457) L-lactate dehydrogenase activity(GO:0004459) |
0.4 | 1.7 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.4 | 1.3 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.4 | 7.7 | GO:0051117 | ATPase binding(GO:0051117) |
0.4 | 13.6 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.4 | 3.3 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.4 | 1.6 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.4 | 3.7 | GO:0019239 | deaminase activity(GO:0019239) |
0.4 | 0.8 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.4 | 0.4 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.4 | 1.2 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.4 | 0.8 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.4 | 0.8 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.4 | 4.3 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.4 | 0.4 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.4 | 6.2 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.4 | 0.4 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.4 | 7.9 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.4 | 0.8 | GO:0005522 | profilin binding(GO:0005522) |
0.4 | 0.7 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.4 | 0.7 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.4 | 2.2 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.4 | 1.4 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) glycine:sodium symporter activity(GO:0015375) |
0.4 | 4.2 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.4 | 12.7 | GO:0019887 | protein kinase regulator activity(GO:0019887) |
0.3 | 2.1 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.3 | 2.4 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.3 | 0.7 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.3 | 1.7 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.3 | 1.3 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.3 | 3.3 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.3 | 3.9 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.3 | 13.7 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.3 | 1.3 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.3 | 1.2 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.3 | 13.3 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.3 | 7.4 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.3 | 2.5 | GO:0048038 | quinone binding(GO:0048038) |
0.3 | 0.9 | GO:0044548 | S100 protein binding(GO:0044548) |
0.3 | 1.2 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.3 | 3.6 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.3 | 0.3 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.3 | 4.2 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.3 | 0.3 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.3 | 0.3 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.3 | 4.0 | GO:0004519 | endonuclease activity(GO:0004519) |
0.3 | 11.6 | GO:0003823 | antigen binding(GO:0003823) |
0.3 | 0.3 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.3 | 0.3 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.3 | 1.4 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.3 | 0.8 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.3 | 25.2 | GO:0003723 | RNA binding(GO:0003723) |
0.3 | 0.5 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.3 | 1.3 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.3 | 1.6 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.3 | 0.3 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.3 | 10.2 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.3 | 0.8 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.2 | 25.9 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.2 | 17.0 | GO:0003774 | motor activity(GO:0003774) |
0.2 | 1.7 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.2 | 0.7 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.2 | 1.0 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.2 | 0.9 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.2 | 0.7 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.2 | 0.7 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.2 | 0.2 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.2 | 36.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.2 | 0.2 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.2 | 0.6 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.2 | 1.1 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.2 | 1.7 | GO:0032451 | demethylase activity(GO:0032451) |
0.2 | 5.5 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.2 | 0.6 | GO:0016015 | morphogen activity(GO:0016015) |
0.2 | 0.8 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.2 | 8.9 | GO:0051015 | actin filament binding(GO:0051015) |
0.2 | 0.6 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.2 | 0.7 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.2 | 0.2 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.2 | 2.8 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.2 | 0.2 | GO:0031433 | telethonin binding(GO:0031433) |
0.2 | 0.8 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.2 | 18.2 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.2 | 0.2 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.2 | 6.9 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) |
0.2 | 4.4 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.2 | 0.2 | GO:0001846 | opsonin binding(GO:0001846) |
0.2 | 0.2 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 3.0 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.1 | 0.5 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.1 | 0.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.1 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 0.4 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.1 | 0.2 | GO:1904680 | oligopeptide transmembrane transporter activity(GO:0035673) peptide transmembrane transporter activity(GO:1904680) |
0.1 | 0.2 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 29.5 | GO:0008270 | zinc ion binding(GO:0008270) |
0.1 | 0.1 | GO:0051540 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.1 | 0.2 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 1.1 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.1 | 0.1 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 0.2 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.1 | 0.1 | GO:0016408 | C-acyltransferase activity(GO:0016408) |
0.1 | 0.2 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.3 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.1 | 1.6 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 0.3 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.1 | 0.3 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.1 | GO:0034212 | peptide N-acetyltransferase activity(GO:0034212) |
0.1 | 0.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.3 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.2 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 1.4 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.6 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.1 | 2.7 | GO:0005496 | steroid binding(GO:0005496) |
0.1 | 0.1 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.1 | 0.3 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.1 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.2 | GO:0016936 | galactoside binding(GO:0016936) |
0.0 | 0.0 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.0 | 0.0 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 0.2 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.0 | 0.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.0 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.0 | 0.0 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.0 | 0.1 | GO:0019825 | oxygen binding(GO:0019825) |
0.0 | 0.5 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.1 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 1.1 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.1 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.0 | 0.0 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.0 | 0.0 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.0 | 1.0 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.3 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.0 | 0.3 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.0 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 1.4 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.0 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.0 | 0.1 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.0 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.0 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.8 | 97.9 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
5.1 | 71.6 | PID IL5 PATHWAY | IL5-mediated signaling events |
4.9 | 49.5 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
4.6 | 9.1 | ST GAQ PATHWAY | G alpha q Pathway |
4.5 | 113.3 | PID IGF1 PATHWAY | IGF1 pathway |
4.5 | 62.6 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
4.1 | 102.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
4.1 | 8.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
4.0 | 24.1 | ST STAT3 PATHWAY | STAT3 Pathway |
4.0 | 172.3 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
3.9 | 141.8 | PID RHOA PATHWAY | RhoA signaling pathway |
3.9 | 69.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
3.8 | 76.2 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
3.8 | 110.0 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
3.8 | 135.5 | PID P53 REGULATION PATHWAY | p53 pathway |
3.6 | 25.5 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
3.6 | 57.0 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
3.5 | 21.3 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
3.5 | 21.2 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
3.5 | 73.9 | PID MYC PATHWAY | C-MYC pathway |
3.4 | 24.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
3.4 | 50.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
3.3 | 143.7 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
3.2 | 22.7 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
3.2 | 13.0 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
3.2 | 35.2 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
3.2 | 34.8 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
3.1 | 34.1 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
3.1 | 71.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
3.1 | 24.5 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
3.0 | 12.2 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
3.0 | 161.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
3.0 | 57.4 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
3.0 | 137.8 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
2.8 | 31.2 | PID IFNG PATHWAY | IFN-gamma pathway |
2.7 | 8.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
2.7 | 48.4 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
2.7 | 88.7 | PID MTOR 4PATHWAY | mTOR signaling pathway |
2.6 | 41.8 | PID TNF PATHWAY | TNF receptor signaling pathway |
2.6 | 28.3 | PID TRAIL PATHWAY | TRAIL signaling pathway |
2.6 | 25.7 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
2.5 | 5.0 | PID EPO PATHWAY | EPO signaling pathway |
2.5 | 5.0 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
2.4 | 68.1 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
2.3 | 16.3 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
2.3 | 50.7 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
2.2 | 20.0 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
2.2 | 71.2 | PID PLK1 PATHWAY | PLK1 signaling events |
2.0 | 73.2 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
2.0 | 68.8 | PID E2F PATHWAY | E2F transcription factor network |
2.0 | 22.1 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
2.0 | 23.8 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
2.0 | 2.0 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
1.9 | 52.0 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
1.9 | 5.6 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
1.8 | 3.7 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
1.8 | 33.0 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
1.8 | 16.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
1.8 | 49.5 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
1.8 | 31.8 | PID ARF6 PATHWAY | Arf6 signaling events |
1.8 | 3.5 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
1.8 | 33.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
1.7 | 1.7 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
1.7 | 25.8 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
1.7 | 51.0 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
1.7 | 8.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
1.7 | 29.7 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
1.6 | 32.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
1.6 | 22.8 | PID BARD1 PATHWAY | BARD1 signaling events |
1.6 | 37.2 | PID ILK PATHWAY | Integrin-linked kinase signaling |
1.6 | 12.6 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
1.6 | 93.3 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
1.6 | 15.7 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
1.6 | 3.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
1.6 | 27.9 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
1.5 | 7.7 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
1.5 | 12.3 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
1.5 | 9.0 | PID CD40 PATHWAY | CD40/CD40L signaling |
1.5 | 1.5 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
1.4 | 31.5 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
1.4 | 25.3 | PID LKB1 PATHWAY | LKB1 signaling events |
1.4 | 18.2 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
1.3 | 4.0 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
1.3 | 9.4 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
1.3 | 13.2 | PID IL1 PATHWAY | IL1-mediated signaling events |
1.3 | 33.0 | PID P73PATHWAY | p73 transcription factor network |
1.3 | 11.8 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
1.3 | 32.7 | PID RAC1 PATHWAY | RAC1 signaling pathway |
1.3 | 9.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
1.3 | 14.1 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
1.3 | 11.5 | PID INSULIN PATHWAY | Insulin Pathway |
1.3 | 36.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
1.3 | 16.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
1.2 | 41.0 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
1.2 | 24.4 | PID FANCONI PATHWAY | Fanconi anemia pathway |
1.2 | 9.4 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
1.1 | 37.2 | PID CMYB PATHWAY | C-MYB transcription factor network |
1.1 | 10.1 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
1.1 | 5.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
1.1 | 5.4 | PID ATR PATHWAY | ATR signaling pathway |
1.1 | 15.0 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
1.1 | 11.7 | SIG CHEMOTAXIS | Genes related to chemotaxis |
1.1 | 4.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
1.0 | 7.3 | PID ATM PATHWAY | ATM pathway |
1.0 | 10.2 | PID ARF 3PATHWAY | Arf1 pathway |
1.0 | 19.3 | PID AURORA B PATHWAY | Aurora B signaling |
1.0 | 19.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.9 | 11.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.9 | 15.8 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.9 | 9.2 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.9 | 6.4 | PID FOXO PATHWAY | FoxO family signaling |
0.9 | 3.6 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.9 | 5.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.8 | 15.8 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.8 | 12.4 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.8 | 5.5 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.8 | 1.6 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.8 | 5.3 | PID BCR 5PATHWAY | BCR signaling pathway |
0.7 | 2.9 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.7 | 8.5 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.7 | 2.1 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.7 | 2.8 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.6 | 3.9 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.5 | 6.5 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.5 | 0.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.5 | 11.5 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.5 | 2.3 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.4 | 6.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.4 | 0.4 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.4 | 9.5 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.4 | 2.9 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.4 | 6.4 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.4 | 3.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.4 | 8.3 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.4 | 5.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.4 | 3.9 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.3 | 5.9 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.3 | 1.7 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.3 | 9.1 | PID NOTCH PATHWAY | Notch signaling pathway |
0.3 | 0.6 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.3 | 2.1 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.3 | 3.7 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.3 | 2.0 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.2 | 1.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 2.2 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.2 | 3.5 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.2 | 2.4 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.2 | 0.8 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 0.2 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.2 | 0.3 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.2 | 0.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 0.9 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.4 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 0.9 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 0.1 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 0.6 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.1 | ST GA12 PATHWAY | G alpha 12 Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
13.5 | 67.5 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
7.3 | 29.0 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
6.6 | 126.3 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
5.8 | 86.8 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
5.6 | 5.6 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
5.6 | 72.6 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
5.4 | 92.0 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
5.4 | 75.1 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
5.0 | 9.9 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
4.9 | 39.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
4.7 | 27.9 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
4.6 | 18.6 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
4.6 | 92.2 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
4.5 | 122.0 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
4.3 | 34.6 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
4.2 | 8.3 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
4.1 | 97.9 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
4.0 | 63.8 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
4.0 | 59.4 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
3.9 | 55.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
3.8 | 42.0 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
3.8 | 79.7 | REACTOME G1 PHASE | Genes involved in G1 Phase |
3.8 | 56.9 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
3.7 | 52.2 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
3.7 | 36.9 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
3.7 | 59.0 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
3.6 | 43.6 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
3.6 | 85.7 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
3.6 | 7.1 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
3.5 | 21.1 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
3.5 | 3.5 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
3.4 | 68.6 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
3.4 | 53.9 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
3.3 | 56.4 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
3.3 | 42.7 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
3.2 | 64.2 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
3.2 | 25.5 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
3.1 | 46.4 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
3.1 | 9.2 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
3.1 | 61.4 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
3.0 | 6.1 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
3.0 | 12.0 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
2.9 | 29.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
2.9 | 46.0 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
2.8 | 52.6 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
2.7 | 11.0 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
2.7 | 16.2 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
2.6 | 23.8 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
2.6 | 13.2 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
2.6 | 15.8 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
2.6 | 179.6 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
2.6 | 20.8 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
2.5 | 66.1 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
2.5 | 2.5 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
2.5 | 5.0 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
2.5 | 41.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
2.4 | 4.9 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
2.4 | 38.5 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
2.4 | 21.5 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
2.3 | 25.0 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
2.2 | 39.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
2.2 | 35.0 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
2.2 | 4.4 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
2.2 | 195.0 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
2.2 | 40.9 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
2.2 | 6.5 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
2.1 | 2.1 | REACTOME ASSEMBLY OF THE PRE REPLICATIVE COMPLEX | Genes involved in Assembly of the pre-replicative complex |
2.1 | 49.0 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
2.1 | 23.4 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
2.1 | 31.5 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
2.1 | 27.2 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
2.1 | 8.3 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
2.0 | 40.9 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
2.0 | 18.4 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
2.0 | 48.7 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
2.0 | 16.1 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
2.0 | 20.1 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
2.0 | 18.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
2.0 | 218.3 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
2.0 | 72.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
2.0 | 11.7 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
2.0 | 11.7 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
1.9 | 31.2 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
1.9 | 1.9 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
1.9 | 1.9 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
1.9 | 30.9 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
1.9 | 17.3 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
1.9 | 43.8 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
1.9 | 24.7 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
1.9 | 20.8 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
1.9 | 47.2 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
1.9 | 63.9 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
1.9 | 1.9 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
1.9 | 5.6 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
1.8 | 7.3 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
1.8 | 34.5 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
1.8 | 27.2 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
1.8 | 18.0 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
1.8 | 17.9 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
1.8 | 32.3 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
1.8 | 62.5 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
1.8 | 3.6 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
1.8 | 19.5 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
1.8 | 45.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
1.7 | 12.2 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
1.7 | 117.7 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
1.7 | 10.3 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
1.7 | 17.1 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
1.7 | 17.1 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
1.7 | 30.6 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
1.7 | 8.5 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
1.7 | 13.5 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
1.7 | 10.1 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
1.7 | 21.8 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
1.7 | 50.3 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
1.7 | 5.0 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
1.6 | 6.5 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
1.6 | 123.6 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
1.6 | 27.5 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
1.6 | 19.0 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
1.6 | 15.7 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
1.5 | 12.4 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
1.5 | 30.4 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
1.5 | 13.6 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
1.5 | 16.5 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
1.5 | 25.5 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
1.5 | 28.4 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
1.4 | 13.0 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
1.4 | 14.3 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
1.4 | 8.6 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
1.4 | 61.0 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
1.4 | 17.0 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
1.4 | 26.4 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
1.4 | 22.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
1.4 | 13.8 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
1.4 | 20.7 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
1.4 | 2.8 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
1.4 | 26.0 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
1.4 | 27.2 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
1.4 | 10.8 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
1.3 | 115.9 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
1.3 | 9.4 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
1.3 | 27.5 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
1.3 | 60.1 | REACTOME TRANSLATION | Genes involved in Translation |
1.3 | 10.4 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
1.3 | 16.6 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
1.3 | 19.0 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
1.3 | 2.5 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
1.3 | 7.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
1.2 | 1.2 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
1.2 | 16.1 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
1.2 | 4.9 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
1.2 | 6.0 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
1.2 | 2.4 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
1.2 | 12.9 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
1.2 | 14.0 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
1.2 | 1.2 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
1.1 | 19.5 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
1.1 | 33.1 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
1.1 | 13.7 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
1.1 | 6.8 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
1.1 | 8.9 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
1.1 | 34.4 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
1.1 | 39.5 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
1.1 | 8.6 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
1.1 | 28.9 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
1.1 | 12.7 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
1.1 | 12.6 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
1.0 | 7.1 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
1.0 | 5.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
1.0 | 10.1 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
1.0 | 10.1 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
1.0 | 10.0 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
1.0 | 14.4 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.9 | 20.5 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.9 | 18.5 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.9 | 5.5 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.9 | 11.7 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.9 | 39.4 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.9 | 7.1 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.9 | 25.7 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.9 | 18.5 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.9 | 7.0 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.9 | 5.1 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.9 | 2.6 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.8 | 31.0 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.8 | 15.5 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.8 | 12.9 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.8 | 3.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.8 | 3.2 | REACTOME CELL CYCLE MITOTIC | Genes involved in Cell Cycle, Mitotic |
0.8 | 1.6 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.8 | 30.2 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.8 | 3.9 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.7 | 5.9 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.7 | 47.5 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.7 | 29.8 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.7 | 40.6 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.7 | 17.6 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.7 | 0.7 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.7 | 2.0 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.6 | 3.8 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.6 | 0.6 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.6 | 16.5 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.6 | 2.4 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.6 | 0.6 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
0.6 | 2.9 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.5 | 5.5 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.5 | 4.2 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.5 | 4.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.5 | 10.2 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.5 | 2.5 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.5 | 1.0 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.5 | 2.4 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.5 | 1.9 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.5 | 0.5 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.4 | 1.3 | REACTOME TRANSCRIPTION | Genes involved in Transcription |
0.4 | 12.2 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.4 | 0.8 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.4 | 2.0 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.4 | 2.7 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.4 | 2.8 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.3 | 0.7 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.3 | 1.6 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.3 | 0.9 | REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
0.3 | 3.8 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.3 | 2.0 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.3 | 4.7 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.3 | 1.9 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.3 | 4.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.2 | 5.7 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.2 | 5.5 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.2 | 2.1 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.2 | 6.5 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.2 | 0.7 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.2 | 3.2 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.2 | 7.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.2 | 1.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 1.3 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 0.5 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 10.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 1.5 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.1 | 0.4 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 0.1 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.1 | 1.4 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 0.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 0.4 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 0.3 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.0 | 0.4 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.1 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.8 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.0 | REACTOME DEFENSINS | Genes involved in Defensins |